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A B S T R A C T
Background
Psychological and educational interventions have been used as an adjunct to conventional therapy for children with atopic eczema to
enhance the effectiveness of topical therapy. This is an update of the original Cochrane review.
Objectives
To assess the effect of psychological and educational interventions for atopic eczema in children.
Search methods
We updated our searches of the following databases to January 2013: the Cochrane Skin Group Specialised Register, CENTRAL in
The Cochrane Library (2012, Issue 12), MEDLINE (from 1946), EMBASE (from 1974), OpenGrey, and PsycINFO (from 1806).
We also searched six trials registers and checked the reference lists of included and excluded studies for further references to relevant
randomised controlled trials (RCTs).
Selection criteria
Randomised controlled trials of psychological or educational interventions, or both, used to assist children and their carers in managing
atopic eczema.
Data collection and analysis
Three authors independently applied eligibility criteria, assessed trial quality, and extracted data. A lack of comparable data prevented
data synthesis, and we were unable to conduct meta-analysis because there were insufficient data.
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Main results
We included 10 RCTs, of which 5 were new to this update; all interventions were adjuncts to conventional therapy and were delivered
in primary- and secondary-care settings. There were 2003 participants in the 9 educational interventions and 44 participants in the 1
psychological study. Some included studies had methodological weaknesses; for example, we judged four studies to have high risk of
detection bias, attrition bias, or other bias. Our primary outcomes were participant-rated global assessment, reduction in disease severity
(reported as objective SCORAD (SCORing Atopic Dermatitis)), and improvement in sleep and quality of life. No study reported
participant-rated global assessment or improvement of sleep.
The largest and most robust study (n = 992) demonstrated significant reduction in disease severity and improvement in quality of
life, in both nurse- and dermatologist-led intervention groups. It provided six standardised, age-appropriate group education sessions.
Statistically significant improvements in objective severity using the SCORAD clinical tool were recorded for all intervention groups
when compared with controls. Improvements in objective severity (intervention minus no intervention) by age group were as follows:
age 3 months to 7 years = 4.2, 95% confidence interval (CI) 1.7 to 6.8; age 8 to 12 years = 6.7, 95% CI 2.1 to 11.2; and age 13 to 18
years = 9.9, 95% CI 4.3 to 15.5. In three of five studies, which could not be combined because of their heterogeneity, the objective
SCORAD measure was statistically significantly better in the intervention group compared with the usual care groups. However, in
all of the above studies, the confidence interval limits do not exceed the minimum clinically important difference of 8.2 for objective
SCORAD.
The largest study measured quality of life using the German ’Quality of life in parents of children with atopic dermatitis’ questionnaire,
a validated tool with five subscales. Parents of children under seven years had significantly better improvements in the intervention
group on all five subscales. Parents of children aged 8 to 12 years experienced significantly better improvements in the intervention
group on 3 of the 5 subscales.
Authors’ conclusions
This update has incorporated five new RCTs using educational interventions as an adjunct to conventional treatment for children
with atopic eczema. We did not identify any further studies using psychological interventions. The inclusion of new studies has not
substantially altered the conclusions from the original review. The educational studies in both the original review and this update
lack detail about intervention design and do not use a complex interventions framework. Few use an explicit theoretical base, and the
components of each intervention are not sufficiently well described to allow replication. A relative lack of rigorously designed trials
provides limited evidence of the effectiveness of educational and psychological interventions in helping to manage the condition of
atopic eczema in children. However, there is some evidence from included paediatric studies using different educational intervention
delivery models (multiprofessional eczema interventions and nurse-led clinics) that these may lead to improvements in disease severity
and quality of life. Educational and psychological interventions require further development using a complex interventions framework.
Comparative evaluation is needed to examine their impact on eczema severity, quality of life, psychological distress, and cost-effectiveness.
There is also a need for comparison of educational interventions with stand-alone psychosocial self-help.
P L A I N L A N G U A G E S U M M A R Y
Psychological and educational interventions for atopic eczema in children
Atopic eczema is an itchy, inflammatory skin condition, which affects the quality of life of children with eczema and their parents
or carers. It affects large and increasing numbers of children worldwide. Psychological and educational approaches have been used to
complement medication in managing eczema, for example, by using simple psychological techniques to manage itching and scratching
or sleep disturbance. Educational interventions, provided to individuals and groups by nurses or teams of specialists in hospital or
community settings, have been used to help parents and children to understand the condition and their role in managing it successfully.
However, the effect of these approaches has not been systematically measured.
We included 10 studies in this review: 5 were in the original review, and 5 were newly incorporated in this update.
Nine studies were educational and predominantly parent-focused (total number of participants n = 2003), and the tenth was a child-
centred psychological intervention (n = 44).
The main finding of this review is that there is currently only limited research evidence about the effect of educational and psychological
approaches when used alongside medicines for the treatment of childhood eczema. Included studies provided a range of interventions,
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from a single 15-minute consultation to a comprehensive series of sessions delivered to groups of parents over a period of 12 hours.
Details of the interventions used and the educational theory base are generally poorly described. Outcome measures varied between
studies.
Although it is not possible to draw definitive conclusions from this review, several studies using educational interventions demonstrated
improvements in eczema severity and quality of life for both children and families. In particular, two studies showed promise. One large
study (n = 992) using a multi-disciplinary group education intervention in a hospital setting showed modest improvements in disease
severity and quality of life. The single study using psychological approaches indicated that relaxation methods reduced the severity of
eczema when compared to discussion only.
There is a need for further research into this subject, and priority should be given to comparing the relative cost effectiveness of health
professionals educating parents either in teams or by nurses alone. There is also a need for comparison with stand-alone self-help. The
most appropriate timeframe for evaluating the effect of interventions should be considered.
B A C K G R O U N D
This is an updated version of an original Cochrane review (Ersser
2007).
Description of the condition
Definition, clinical features, and epidemiology
Atopic eczema (or atopic dermatitis) is an itchy, inflammatory
skin disease, often involving skin creases (Williams 2005). The
condition may be acute with redness, scaling, oozing, and vesi-
cles, or it may be chronic with associated skin thickening, altered
pigmentation, and exaggerated surface markings. Itching is a ma-
jor symptom that can develop into a cycle of scratching, causing
skin damage and in turn more itching (the itch-scratch cycle).
Atopic eczema is now themost common inflammatory skin disease
of childhood, affecting large and increasing numbers of children
worldwide (Asher 2006).Whilst the number of adults with atopic
eczema is smaller (1% to 2%), their disease is frequently more
chronic and severe (Herd 1996). Approximately 70% of cases start
in children under the age of 5 (Hanifin 2007). Evidence suggests
that the prevalence of atopic eczema has increased two- to three-
fold over the last 30 years (Schram 2010). The reasons for this are
not entirely clear but are likely to be environmental, as significant
differences in prevalence between populations of the same ethnic
background have frequently been found, for instance between ur-
ban and rural areas (Schram 2010).
Causes
Nevertheless, genetic factors are important in the development of
eczema, as has been repeatedly shown in association with carriage
of filaggrin (FLG) loss-of-functionmutations (Palmer 2006; Smith
2006); FLG is a gene that has a pivotal role in skin barrier function.
Filaggrin forms part of the cornified cell envelope (the ’mortar’
of the ’brick-and mortar’ structure of the epidermis). Reduced
expression or complete lack of FLG therefore leads to an impaired
skin barrier. Approximately 40% of children with moderate to
severe eczema carry at least one FLG mutation, which predisposes
to early onset eczema, disease severity, and chronicity. However,
as a significant proportion of children with eczema do not carry a
FLG mutation, other genetic factors are likely to play a role, too
(Paternoster 2012).
The current hypothesis is that where people carry a skin barrier
gene mutation, such as a loss-of-function mutation in the filag-
grin gene, the skin barrier is impaired, leading to an increase in
transepidermal water loss (water loss across the superficial skin)
and therefore skin dryness (Flohr 2010). Probably in interaction
with environmental factors, such as water hardness and frequent
use of protease-containing detergents and soaps, the integrity of
the skin barrier is gradually broken down further, and this may
lead to the typical immunological changes seen in eczematous skin
(Cork 2006;McNally 1998; Sherriff 2002). Animal work suggests
that environmental allergens, such as house dust mites, but also
food protein, can make contact with the immune system via anti-
gen-presenting cells in the superficial epidermis, leading to sen-
sitisation. This can make existing eczema worse and may also be
an important precursor of food and respiratory allergies (Fallon
2009). This would explain why FLG mutations are only associ-
ated with asthma in the presence of eczema or allergic sensitisation
(van den Oord 2009). However, prospective studies are required
to examine the exact sequence of events.
Impact
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Measurement of the impact of skin disease on quality of life and
emotional well-being is important for our understanding andman-
agement of skin conditions as psychosocial factors play an impor-
tant role in the itch-scratch cycle (Verhoeven 2008). Several stud-
ies suggest that atopic eczema has a greater detrimental impact
on quality of life than other skin diseases, such as acne and pso-
riasis (Lewis-Jones 1995); therefore, it is desirable to measure the
impact on quality of life as a potential outcome of interventions
(Lewis-Jones 1995). It is notable that whilst detrimental impact on
quality of life is common, non-adherence to treatment regimens
continues to be problematic, with parents reporting dissatisfaction
with the ’trial and error’ approach to treatment often experienced
in primary care (Santer 2012). The relationship between the sever-
ity of atopic eczema in children and adolescents and quality of life
has been established (Ben-Gashir 2004). Problematic symptoms,
such as itching, can adversely affect quality of life. Itch leads to
scratching, which may have a significant detrimental impact on
a child’s sleep, quality of life (Lewis-Jones 2001; Williams 1997),
and family life (Elliott 1997; Johnson 1991). Because of the vari-
ous impacts of atopic eczema, it is necessary to measure changes in
disease severity as a key outcome measure. Also, since caregivers,
especially parents, are often required to assist with treatments, their
ability and confidence are relevant outcomes to measure. Given
that children and adolescents with atopic eczema require special
clothing, bedding, frequent applications of greasy ointments, and
may need to avoid activities such as swimming (Reid 1995), treat-
ment adherence becomes a relevant outcome to measure. There is
also a substantial economic cost to the family (Kemp 2003) and
the health service (Verboom 2002).
Description of the intervention
Educational and psychological interventions, where available, are
invariably provided in conjunction with conventional therapy.
Such interventions may be directed towards the parent or child,
with parents tending to be the primary focus of the educational
approaches and children the main target of psychological inter-
ventions. A child’s ability to participate effectively in an educa-
tional or psychological intervention will depend on the suitability
of the activity for their age and developmental stage. Educational
interventions are often used in supporting people with long-term
conditions to optimise care. A recent example of this in the der-
matology field is the Eczema Education Programme. This is one
of the largest parental eczema education programmes in Europe
and has been subject to extensive evaluation in a non-controlled
trial (Ersser 2013; Jackson 2013). An example of a psychological
(primarily behavioural) intervention is habit reversal, identified as
a method of eliminating nervous habits and tics, whereby an al-
ternative or competing behaviour is adopted in place of the un-
desirable behaviour (Miltenberger 1998). Other types of psycho-
logical intervention might include cognitive behavioural therapy,
counselling, and arousal reduction techniques, such as relaxation
and mindfulness.
a) Psychological interventions
The main types of psychological intervention available are sum-
marised briefly below. All of these approaches can be delivered
either in an individual or group format, although more in-depth
psychological therapy tends to be provided on a one-to-one basis.
1. Psychological techniques using arousal reduction
techniques
These are essentially all very similar relaxation techniques, which
may include the following.
• Progressive relaxation: a technique that relies on tensing
different muscles in the body and then releasing that tension.
This enables an individual to recognise areas of tension and to
consciously learn to release that tension.
• Autogenic training: a systematic form of relaxation
involving increasing awareness of the body.
• Guided imagery or ’visualisation’: learning to use imagery
associated with relaxation or calmness and attempting to induce
the related feeling in one’s own body.
• Biofeedback: here a person learns how to recognise and
manage physiological responses through feedback usually
facilitated by the use of instrumentation.
• Hypnotherapy: involves creating a state whereby an
individual is suggestible. It is often used to create a feeling of
relaxation and is consequently included here.
2. Behavioural interventions
• Behaviour therapy involves the application of behavioural
theory to modify behaviours.
• Habit reversal is a form of behavioural intervention used to
modify unhelpful scratching.
• Other forms of behavioural intervention may include
caregiver training programmes whereby carers are trained in the
use of contingency management systems (for example, through
the systematic use of charts to record and reward progress).
3. Psychological therapies focused on internal processes
There are a number of therapies that might broadly be referred to
as ’talking therapies’, and these are generally associated with raising
insight and may or may not involve the use of specific techniques
to change internal psychological processes, external behaviour, and
coping styles.
• Cognitive behavioural therapy takes a biopsychosocial
perspective that involves the promotion of an empiricist
approach, i.e. assisting an individual in understanding the links
between their thoughts, thinking processes, and behaviours. As
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well as drawing on cognitive theories, it also draws on
behavioural theories and techniques. It is problem-focused and
may use a range of techniques to raise awareness of - and so to
change specific thoughts - cognitive processes, feelings, or
behaviour and to enhance coping strategies.
• Counselling: usually non-directive, non-judgemental,
empathetic, and supportive approaches, which enable an
individual to cope more effectively with their problems or inner
states.
• Family therapy: views the family, rather than the individual
member, as the unit requiring assistance. Types of family therapy
all involve encouraging family members to talk to one another,
examining inflexibilities, family rules and beliefs, focusing on
relationships within the family and those between the family and
external agencies, e.g. health, education, occupation, and social
services.
• Psychodynamic approaches place emphasis on unconscious
motives and drives. The aim of the therapy is the recognition of
unhelpful defences and the linkage of these to underlying
conflicts. This may include focusing on the past and making use
of the relationship between the patient and the therapist to
understand the origin and maintenance of distress.
b) Educational Interventions
Wolf 2002 defines educational interventions as, ’any intervention
targeted at children (or their caregivers) designed to teach one or
more management strategies related to prevention, management,
or the use of social skills’. We included these interventions, which
can use ’any instructional strategy or combination of strategies
(problem solving, role-playing, videotapes, computer-assisted in-
struction, booklets, etc) and be presented either individually or in
group sessions’ (Wolf 2002), in this review.
Dermatological educational and psychological behaviour-change
techniques may be combined to support secondary prevention
(Gieler 2000). Educational interventions are focused on the pro-
cess of acquiring new knowledge or skills through teaching and
learning activities. An approachwhere information-giving and for-
mal teaching leads the recipients to become more accurately in-
formed about their condition means they are better prepared to
understand the need for medical interventions and effective dis-
ease management. The content of educational interventions may
include information on the disease, treatment instructions, man-
agement, and prevention strategies, and may be delivered in hos-
pital or community settings. There is growing awareness that edu-
cation, in the form of imparting knowledge alone, will not lead to
improved outcome. In recent years, there has been increased use of
self-efficacy-based interventions that build knowledge, skills, and
confidence (Bandura 1997) to enable people to self-manage long-
term conditions as effectively as possible (Ersser 2011). Motiva-
tion and intention to change are important factors in educational
interventions, and it is well recognised that intention to change
does not necessarily lead to health behaviour change (Webb 2006).
Therefore, it is important to plan some follow up from such in-
terventions.
How the intervention might work
Educational interventions have been used in the management of
long-term conditions in adultswith positive outcomes.However, it
is evident that interventions based solely on education are unlikely
to bring about health behaviour change. Whilst the ’active ingre-
dients’ of successful interventions remain unclear (Coster 2009),
they are likely to include the participant’s motivation; shared de-
cision-making; development of problem-solving skills; goal set-
ting and agreeing action plans (Coulter 2006; Health Foundation
2011); and ensuring that people have sufficient knowledge, skills,
and confidence to self-manage as effectively as possible (Bandura
1997). A range of theories can be applied to the development of
educational interventions in health care. Of particular importance
is the relationship between intention and actual behaviour change.
The theory of planned behaviour, the theory of reasoned action,
and self-regulation theory have been successfully integrated into
interventions (Webb 2006).
Many existing educational programmes for long-term conditions
are based on Social Learning Theory (SLT) (Bandura 1997). A
core concept of SLT is self-efficacy, that is, the belief that a person
has that they are able to successfully initiate and complete actions
needed to achieve a specific outcome (Ersser 2011). To be able to
self-manage as effectively as possible, people need to have sufficient
knowledge, skills, and confidence; attributes that can be developed
through the application of self-efficacy theory-based educational
interventions. This approach has been applied with promising
results in adult psoriasis (Ersser 2011). In childhood eczema, any
such intervention would primarily be aimed at the parent or carer.
Techniques such as habit reversal work on the premise that scratch-
ing has become unconscious and generalised beyond the experi-
ence of itch. It therefore aims to bring into conscious awareness the
repetitive scratching by use of a recording technique, whichmay in
itself reduce the urge to scratch. In addition, habit reversal teaches
how to use alternative less damaging behaviours where the itch
persists. Some of the other simple psychological techniques, such
as relaxation, may simply work by reducing arousal and stress that
may heighten the perception of itch. More complex psychological
interventions may be necessary where there are secondary gains or
unhelpful coping responses contributing to the presentation.
All the educational and psychological interventions reviewed have
been used as adjuncts to conventional eczema treatments, includ-
ing topical and systemic therapies.
Why it is important to do this review
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Since atopic eczema affects significant numbers of children and
can be disabling for whole families, psychological support and ed-
ucation of the parent or carer are essential components of disease
management. Little is known however of the measurable effects
of such interventions. In the original version of this review, Ersser
2007 found only limited evidence to support psychological or edu-
cational interventions. However, management strategies to reduce
scratching behaviours that exacerbate eczema are incorporating
psychological interventions, and treatment guidelines are begin-
ning to recommend them (Giannini 1997; Ring 2012). Despite
the fact that parents are the primary carers for children with atopic
eczema, very limited attention has been given to the psychological
support of parents (by educational or psychological intervention).
As such, the caregiver’s ability to manage their child’s eczema is
an important outcome; therefore, the educational or psycholog-
ical support given to parents is relevant to this review. However,
it is recognised that psychological support to both caregiver and
child are important. The general case for psychosocial interven-
tions to improve clinical outcomes in organic disease is established
(Williams 2002) and also in related areas, such as asthma (Guevara
2003).
The literature refers to a range of psychological interventions that
have been used in atopic eczema, such as behavioural management
(Bridgett 1995; Bridgett 2000; Norén 1989), relaxation therapy
(de L Horne 1999), and cognitive behavioural therapy (Ehlers
1995). Clinical observations suggest that behavioural techniques
can be a useful adjunct to topical therapy, and breaking the itch-
scratch cycle is argued to be a primary clinical aim (Hägermark
1995). However, evaluative research has been limited (Bridgett
2000; Ersser 2007; Simpson-Dent 1999), especially with children.
Educational interventions have also been used to bring about be-
havioural change through patient education or patient teaching
for those with eczema (Niebel 2000). These educational interven-
tions are important since chronic disease management requires a
degree of self management (or caregiver or parental support) and
therefore educational and behavioural change (Holman 2000). A
limited number of evaluative studies have examined the impact of
parental education on the management of atopic eczema in chil-
dren.
O B J E C T I V E S
To assess the effect of psychological and educational interventions
for atopic eczema in children.
M E T H O D S
Criteria for considering studies for this review
Types of studies
Randomised controlled trials (RCTs).
Types of participants
Children, adolescents, or infants with atopic eczema and their
caregivers (including parents).
Types of interventions
We anticipated that most studies would be of conventional treat-
ment alone versus conventional plus psychological or educational
interventions and that we would be unlikely to find trials examin-
ing purely psychological or educational approaches. Some inter-
ventions that are psychologically- or educationally-based, focused
on the parent, the child, or both, and depended upon the devel-
opmental stage of the child.
Whilst some RCTs of therapies had an educational or psychologi-
cal component, in this review, we only included studies where the
educational or psychological intervention was the primary inter-
vention to which the experimental group was exposed.
Types of outcome measures
Outcome measures for eczema interventions have recently been
addressed by the HOME (Harmonising Outcome Measures for
Eczema) initiative, following aDelphi exercise. The core outcomes
that all eczema-related RCTs should report on are as follows: clin-
ical signs, symptoms, long-term control of flares, and quality of
life (Schmitt 2012).
The following outcomes, influenced by the HOME work, were of
interest to us as measured by participant, carer, clinician, or other
trial outcome observer, or any combination. Specifically, we were
concerned with a clinically significant response in the following
outcomes.
Primary outcomes
1. The participant-rated global assessment was the primary
outcome measure if available. We refer here to the evaluation of
the participant deeming the intervention to be effective or
helpful or ineffective or unhelpful as an outcome measure. If this
was not available, we used the medical practitioner global rating
(percentage with good or excellent improvement).
2. Reduction in disease severity as measured by a trained
assessor (Minimal Clinically Important Difference (MCID) is
8.7 points for the SCORAD, 8.2 for the objective SCORAD, 6.6
for the EASI (Eczema Area and Severity Index), and 3.4 for the
POEM (Patient Orientated Eczema Measure)) (Schram 2012).
3. Improvement in sleep.
4. Improvement in quality of life or reduction in distress of
the child and parent (caregiver).
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Secondary outcomes
1. Reduction in harmful scratching behaviour (using, for
example, digital accelerometers or video recordings of patients
(Benjamin 2004)).
2. Improvement in treatment adherence.
3. Reduction of medication usage (particularly anti-
inflammatory or immunosuppressant treatments)*.
4. Enhancement of caregivers’ actual and perceived ability to
manage atopic eczema in their child (e.g. self-efficacy (self-
confidence), locus of control (distinguishing those who attribute
events to either their own control or to external circumstances)
and coping measures)**.
We took into account, in addition to the measures above, adverse
effects such as inconvenience and cost.We accepted outcomemea-
sures however they were designed and implemented, although this
was accompanied by a critical evaluation of the rigour of the mea-
sures used (attention to reliability and validity issues). The con-
ventional treatment used in a trial will be an important charac-
teristic that may influence the effectiveness of the psychological
or educational intervention, and we considered this as a possible
source of heterogeneity.
∗Itisrecognisedthatmedicationusagemaygoupbecauseof improvedadherence,oritmaygodownbecausetheeczemahasimprovedasaresultofpsychological/educationalintervention.
∗∗T hisoutcomeallowsforthef actthatthebenef itsofpsychologicalsupportoreducationmaynotbeprimarily′medical′ .
Search methods for identification of studies
Weaimed to identify all RCTs regardless of language or publication
status (published, unpublished, in press, or in progress).
Electronic searches
For this update, we revised and updated our search strategies, and
searched the following databases up to 17 January 2013:
• the Cochrane Skin Group Specialised Register using the
search strategy in Appendix 1;
• the Cochrane Central Register of Controlled Trials
(CENTRAL) in The Cochrane Library (2012, Issue 12) using the
strategy in Appendix 2;
• MEDLINE via OVID (from 1946) using the strategy in
Appendix 3;
• EMBASE via OVID (from 1974) using the strategy in
Appendix 4;
• PsycINFO via OVID (from 1806) using the search strategy
Appendix 5; and
• CINAHL Plus with Full Text (1937 to 2013) using the
search strategy in Appendix 6 (searched up to 22 November
2013).
A final prepublication search of the above databases was under-
taken on 19 November 2013. Although it has not been possible to
incorporate RCTs identified through this searchwithin this review,
relevant references are listed under Studies awaiting classification.
They will be incorporated into the next update of the review.
Trials registers
For this update, we searched the following trials registers up to 22
November 2013:
• Current Controlled Trials ISRCTN (www.controlled-
trials.com/isrctn/), using the following search phrase: (eczema
OR dermat*) AND (child* OR infant*).
• The UK Clinical Trials Gateway (www.ukctg.nihr.ac.uk/
default.aspx), searching for the conditions Eczema or “atopic
dermatitis”.
• The US National Institutes of Health Ongoing Trials
Register (www.clinicaltrials.gov), using the terms (child OR
children ORchildhood ORinfantORinfantsORinfancy
ORinfantile) AND (eczema OR dermatitis OR dermatology )
AND (psychology OR psychological OR education OR educational
OR educating).
• The Australian New Zealand Clinical Trials Registry (
www.anzctr.org.au), using the terms eczema OR “atopic
dermatitis”.
• The World Health Organization International Clinical
Trials Registry platform (www.who.int/trialsearch) using the
terms eczema OR “atopic dermatitis” as a condition, then
searching the subset of Clinical trials in children.
• The EU Clinical Trials Register (https://
www.clinicaltrialsregister.eu/), using the terms eczema OR atopic
dermatitis, limited to age range: children and infant and toddler.
Searching other resources
References from published studies
We checked the bibliographies of included and excluded studies
for further references to relevant trials.
Unpublished literature
We searched for grey literature using the OpenGrey database (
www.opengrey.eu/) up to 22 November 2013, using the follow-
ing search terms: (eczema OR dermat*) AND (child* OR infant*)
AND (psych* OR educ*).
Conference proceedings
We did not search Zetoc Alerts for additional conference proceed-
ing that were not expected to be covered by the Cochrane Skin
Group Specialised Register for this update.
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Adverse effects
We did not perform a separate search for adverse effects. However,
we did examine data on adverse effects from the included studies
we identified.
Data collection and analysis
Selection of studies
We only considered randomised controlled trials (RCTs). Two
authors (FC and SE) checked titles and abstracts identified from
the searches. We excluded studies that did not refer to an RCT on
atopic eczema. Three authors (FC, SE, and SML) obtained the full
texts of studies for independent assessment to decide which trials
fulfilled the inclusion criteria. They resolved any disagreement by
discussion between all the authors.
Data extraction and management
Three authors (FC, SML, and EG) independently performed data
extraction and management, entering data onto a data extraction
form. They discussed all discrepancies and achieved a consensus
for each paper. The authors entered all study information and the
included RCTs results into Review Manager (RevMan) for data
management. They were not blinded to the names of authors,
journals, or institutions.
Assessment of risk of bias in included studies
We addressed the following four areas since there is reported evi-
dence that these are associated with biased estimates of treatment
effect (Juni 2001):
a) randomisation (method of generation and concealment of allo-
cation);
b) blinding of observers (blinding of participants was not possible
because of the nature of the intervention);
c) loss to follow up (presence of dropouts and withdrawals and the
analysis of these); and
d) other bias.
The quality assessment included an evaluation of the following
components for each included study. Each component was cate-
gorised as low risk, unclear risk, or high risk on the data extraction
form as advised by theCochraneHandbook for Systematic Reviews of
Interventions (Higgins 2011). Criteria for judgement of adequacy
are as follows.
• Randomisation: Adequate studies used a randomised
sequence from a computer-generated procedure or shuffled
envelopes. Unclear studies provided insufficient information,
and we excluded those employing alternations.
• Concealment of allocation sequences: In adequate studies,
the assignment could not be foreseen (allocation concealment).
Low risk included techniques such as the use of a third party or
use of opaque sealed envelopes. High-risk techniques included
those such as having an open list or in accordance with days of
the week.
• Blinding: In adequate studies, this took place after
allocation assignment and ensured the outcome assessor,
participants, and clinicians were unaware of any allocation
sequence. In our case, determining adequacy did not relate to all
three areas of blinding as this was not practical for our included
studies. We addressed this issue in the methodological quality
assessment section.
• Loss to follow up: when more than 80% of participants
were followed up and then were analysed in the groups to which
they were originally randomised (intention-to-treat). We also
included as low risk those studies in which intention-to-treat
(ITT) analysis was undertaken but with minimal missing
outcome data. We specified inadequate loss to follow up when
there was no ITT analysis or substantial missing data, as well as
less than 80% follow up.
• Selective outcome reporting bias: We checked whether
findings for all outcomes listed in the Methods sections were
reported.
In addition, we assessed the following as required:
e) degree of certainty that participants have atopic eczema;
f ) baseline comparison for severity of disease; and
g) comparability at baseline for all primary outcome variables.
Measures of treatment effect
If data synthesis were possible, we planned to calculate a weighted
treatment effect across trials using a random-effects model. For
dichotomous outcomes, our planned treatment effectmeasure was
the odds ratio, and for continuous data, our planned treatment
effect measure was the weighted mean difference. We planned
to used standardised mean differences if different studies used
different scales for a continuous outcome.
Unit of analysis issues
We planned to analyse any cross-over trials included in the review
separately from the parallel group trials before pooling the results.
Dealing with missing data
If practical, we planned to carry out a sensitivity analysis to exam-
ine the impact on the overall treatment effect if some studies had
substantial missing data. If feasible, we planned to do this by carry-
ing out a meta-analysis twice, firstly with all studies included and
then secondly by excluding the studies with substantial missing
data and also studies with higher levels of other potential biases.
8Psychological and educational interventions for atopic eczema in children (Review)
Copyright © 2014 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Assessment of heterogeneity
We planned to test for heterogeneity of the intervention effect us-
ing the I² statistic. If this statistic suggested significant heterogene-
ity, we then planned to check if this was due to a single ’outlier’
study. If so, we planned to perform and report meta-analyses both
with and without this study. On the other hand, if there were no
clear outlying studies, we planned to try to establish the causes of
heterogeneity and decide whether meta-analysis was feasible.
Assessment of reporting biases
We planned to assess reporting bias using funnel plots if we in-
cluded at least 10 studies in the review and a meta-analysis was
feasible.
Data synthesis
Weplanned to assess whether each of our outcomes of interest were
measured in a large enough subset of studies for a meta-analysis
to be viable (i.e. the clinical diversity was not too great). We also
planned to assess whether the intervention and control groups
in each study and the study designs were sufficiently consistent
for us to synthesise a global intervention effect. If the number of
included studies in the review was very small or they were too
diverse, we planned to present a narrative analysis that included
details of individual study results instead of a meta-analysis.
Subgroup analysis and investigation of heterogeneity
If sufficient study information was available, we planned to per-
form subgroup analysis using age or developmental stage as the
grouping factor. As mentioned above, we planned to use the I²
statistic to investigate heterogeneity.
Sensitivity analysis
If possible, we planned to do sensitivity analyses to examine the
change in overall intervention effect estimates from ameta-analysis
by excluding studies with lower methodological quality.
R E S U L T S
Description of studies
Results of the search
The search for this update identified 1844 studies. We assessed
each title and abstract and rejected 1839 studies as they did not
meet the inclusion criteria. The majority of studies identified were
in English, but other languages encountered included German,
Spanish, Italian, and French. We conducted translations as re-
quired.
The original review included five RCTs (Chinn 2002; Niebel
2000; Sokel 1993; Staab 2002; Staab 2006), and we added a
further five in the update process (Grillo 2006; Moore 2009;
Schuttelaar 2010; Shaw 2008;Weber 2008). The study by Kupfer
was based on data from Staab 2006 that had already been included
in the original review, so we added it as a subsidiary reference to
Staab 2006. It is important tomention that all studies used conven-
tional topical treatments in combination with either educational
or psychological interventions. It was unlikely that we would find
a study whereby psychological or educational interventions were
assessed in isolation from conventional therapy; this was evident
throughout the review.
Included studies
We included 10 RCTs in the review, with a total of 2003 partici-
pants in studies employing educational interventions, and 44 par-
ticipants in the single psychological intervention study. We give
details in the ’Characteristics of included studies’ tables.
Design
All 10 studies employed a parallel group design.
Sample sizes
The number of participants randomised were as follows: Sokel
1993 (n = 44); Niebel 2000 (n = 47); Chinn 2002 (n = 240); Staab
2002 (n = 204); Staab 2006 (n = 992); Grillo 2006 (n = 61); Shaw
2008 (n = 151); Moore 2009 (n = 112); Weber 2008 (n = 36);
and Schuttelaar 2010 (n = 160). Total number of participants =
2047.
Setting
Only one study was primary-care-based (Chinn 2002), and five
were hospital-based: Niebel 2000; Schuttelaar 2010; Shaw 2008;
Staab 2002; Staab 2006. Two implied they were hospital-based
(Grillo 2006; Moore 2009), and the settings for the studies by
Sokel 1993 and Weber 2008 remain unclear.
Three studies were conducted in Germany (Niebel 2000; Staab
2002; Staab 2006), two in the UK (Chinn 2002; Sokel 1993),
two in Australia (Grillo 2006; Moore 2009), one in Brazil (Weber
2008), one in the USA (Shaw 2008), and one in the Netherlands
(Schuttelaar 2010).
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Participants
In all the educational studies, the participants were the child-par-
ent dyad; by this, we refer to the unit of both the parent and the
child. In the Sokel 1993 study, the participant was the child only.
The age of the children ranged from infants (age not specified) to
16 years old.
Interventions
Of the 10 RCTs included, 9 focused on educating parents to self-
manage their child’s atopic eczema (Chinn 2002; Grillo 2006;
Moore 2009; Niebel 2000; Schuttelaar 2010; Shaw 2008; Staab
2002; Staab 2006; Weber 2008), with one including a child com-
ponent (Weber 2008). The other examined psychological or com-
plementary intervention techniques (hypnotherapy and biofeed-
back) to improve the quality of life of children with atopic eczema
(Sokel 1993). The nine RCTs focusing on parental education used
a variety of intervention formats. Parents of children with atopic
eczema were given multiple training sessions in five of the studies
(Niebel 2000; Schuttelaar 2010; Staab 2002; Staab 2006; Weber
2008), but only one training session in the other four (Chinn 2002;
Grillo 2006; Moore 2009; Shaw 2008). In relation to the health
professionals administering the parental education programmes,
four studies were nurse-led (Chinn 2002; Moore 2009; Niebel
2000; Schuttelaar 2010), twoweremulti-disciplinary (Staab 2002;
Staab 2006), one was medically led (Weber 2008), one was led
by a senior medical student (Shaw 2008), and the leadership of
the Grillo 2006 study remains unclear. Niebel 2000;Moore 2009;
Staab 2002; Staab 2006; and Weber 2008 delivered group inter-
ventions. Schuttelaar 2010 delivered a combination of individual
and group input. Chinn 2002 and Shaw 2008 used one-to-one
interventions. The delivery of the educational interventions varied
in relation to their timing and duration of the various elements of
delivery.
Outcomes
The main outcome data from the included studies used across
more than one study was that of severity, for which different mea-
sures were used. SCORADwas used in the studies by Grillo 2006;
Moore 2009; Niebel 2000; Schuttelaar 2010; Shaw 2008; Staab
2002; and Staab 2006. Despite this, the difference in interven-
tion delivery (whether nurse-led ormulti-disciplinary-led) and the
form in which the data were available for each study meant the
scope for synthesis was limited. It was thought that little additional
information would be gained by drawing together the data from
the Staab 2002 and Staab 2006 studies. Two within-study com-
parisons were theoretically possible for two of the included studies
having two or more intervention groups. One compared differ-
ent methods of relaxation-biofeedback and hypnotherapy (Sokel
1993), and the other compared different types of educational de-
livery: direct and video-mediated (Niebel 2000). The Sokel 1993
study used a newly developed, but unvalidated, severitymeasure in
the comparison of the different intervention groups for three pa-
rameters of disease severity; this preceded the availability of SCO-
RAD.
Several studies employed quality of life measures, predominately
the Children’s Dermatology Life Quality Index (CDLQI) +/- the
Infant Dermatitis Quality of Life Index (IDQOL) (Chinn 2002;
Grillo 2006; Schuttelaar 2010; Shaw 2008; Weber 2008), and
Staab 2002 and Staab 2006 used a generic quality of life instru-
ment. Again, differences in intervention delivery and the form in
which the data were available for each study meant the scope for
synthesis was limited.
None of the included studies addressed the following of our pre-
specified outcomes: participant global assessment; improvement
of sleep as a separate measure, although there is an item within the
SCORAD severity measure embracing sleep impact; reduction of
medication usage; and enhancement of caregiver ability to manage
atopic eczema in the child.
The included studies did not report adverse effects.
Excluded studies
In total, we excluded five studies from the review after the pro-
cess of excluding by title and abstract. We give details in the
’Characteristics of excluded studies’ tables.
• Of the six excluded studies, three involved adults: Bae 2012
indicated in the abstract both child and adult involvement;
however, the mean age was 23.5; the youngest participant was
12; and all data were presented collectively. Unpublished data
obtained for the Greene 1997 study established that participants
were adults. van Os-Mendendorp 2012 included both children
and adults in an RCT, and when contacted, the author
confirmed that it was not possible to disaggregate the data.
• Two RCTs designed to educate the parents of children with
atopic eczema (Broberg 1990; Kardorff 2003) had originally
been deemed suitable for inclusion. In one paper (Broberg
1990), missing data were derived from data figures and graphs,
but after subsequent enquiry with the author, we excluded the
paper because of inadequate randomisation. Translation of the
Kardorff 2003 paper and further correspondence with the author
also provided evidence to exclude this RCT since adequate
randomisation of the participants had not occurred (Altman
1999). In each case, alternation was used; the participants were
alternately allocated to the two study groups in order of their
attendance at clinic: one into the control group, then
experimental, then control, and so on. This is despite Broberg
stating in the abstract that the participants were ’randomly
assigned’ and were ’divided into two random groups’; subsequent
evidence demonstrated that this claim was inaccurate.
Studies awaiting classification
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One study, Futamura 2013, is awaiting classification. For details,
please see the ’Characteristics of studies awaiting classification’
table.
Ongoing trials
Our searches of the trials registers retrieved 339 results, fromwhich
we identified four relevant trials.
• ISRCTN98560867 (Supporting parents’ and carers’
management of childhood eczema).
• N0060047013 (The project involved behavioural therapy
(habit-reversal) versus conventional medical management with
children living with severe atopic eczema. The research question
focused on whether a habit-reversal programme might alter the
natural history of atopic eczema and whether this is measurable
in blood and skin samples. Correspondence with the trial
authors revealed that the study had been suspended due to the
loss of the principal investigator).
• NCT01138761 (Health literacy for children with atopic
dermatitis and their caregivers (active, not recruiting 2011)).
• NCT01143012 (Group Eczema Education Visits: Impact
on Patient and Family Quality of Life).
For details of these ongoing studies, please see the ’Characteristics
of ongoing studies’ tables.
Risk of bias in included studies
Please see Figure 1 for our judgements about each ’Risk of bias’
itempresented as percentages across all included studies, andplease
see Figure 2 for our judgements about each ’Risk of bias’ item for
each included study.
Figure 1. ’Risk of bias’ graph: review authors’ judgements about each ’Risk of bias’ item presented as
percentages across all included studies
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Figure 2. ’Risk of bias’ summary: review authors’ judgements about each ’Risk of bias’ item for each
included study
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Allocation
Randomisation
According to the published papers, all 10 of the included studies
randomly allocated the participants to either control or experimen-
tal groups. Six studies used computer software to generate random
sequences (Chinn 2002; Grillo 2006; Moore 2009; Schuttelaar
2010; Shaw 2008; Staab 2006), so we judged these as at low risk
of bias. The other four studies (Niebel 2000; Sokel 1993; Staab
2002; Weber 2008) claimed to have randomised the participants
but did not state the precise method by which this was achieved.
Allocation concealment
We considered the concealment of participant allocation to groups
as low risk in 4of the 10 included studies (Moore 2009; Schuttelaar
2010; Shaw 2008; Staab 2006). We could not adequately assess
the remaining six (Chinn 2002; Grillo 2006; Niebel 2000; Sokel
1993; Staab 2002; Weber 2008) because of a lack of information
in the published reports. Correspondence with Dr Chinn indi-
cated that a list of subject numbers were generated at the start
of the study; participants were allocated according to this list in
the order each participant returned their baseline questionnaire.
This was conducted independently of their practice or their nurse;
the nurse was then informed to which group each participant had
been assigned.
Blinding
In all 10 included studies, it was impossible to blind the inter-
vention, so participants were not blinded to their group alloca-
tion. Four studies blinded the outcome assessor (Chinn 2002;
Schuttelaar 2010; Sokel 1993; Staab 2006), and 1 checked on 10
participants using an independent blinded assessor (Moore 2009);
we judged these 5 studies as at low risk of bias. Four were un-
clear (Grillo 2006; Niebel 2000; Shaw 2008; Weber 2008), and
one (Staab 2002) used parent-documented outcome measures; we
judged the latter as at high risk of bias for this domain.
Incomplete outcome data
Loss to follow up
Seven studies (Chinn 2002; Grillo 2006; Moore 2009; Niebel
2000; Schuttelaar 2010; Staab 2006; Weber 2008) presented data
for > 80% of participants, and we judged them to be low risk for
attrition bias. Staab 2002 was unclear in the description of loss to
follow up; limited information suggests that follow-up was 77%
in 1 group and 66% in the other, so we assessed this as at high
risk of bias. Follow-up was more clearly presented in a different
but later study (Staab 2006); no ITT analysis was undertaken, and
twice as many participants were lost to follow up in the control
arm than the intervention group. Shaw 2008 and Sokel 1993 had
substantial missing data, and no ITT analysis was performed, so
we assessed these as at high risk of bias.
Selective reporting
All 10 studies reported findings on all outcomes listed in theMeth-
ods section. Therefore, we judged selective reporting bias to be
low for all 10 studies.
Other potential sources of bias
Topic-specific considerations
All 10 included studies stated that their groups were comparable
at baseline assessment. However, in the Chinn 2002 study, the dis-
tribution of baseline IDQOL and Family Dermatitis Index (FDI)
scores differed significantly between those who returned all ques-
tionnaires and dropouts. The latter had worse quality of life (QoL)
and FDI scores at baseline, so we judged this study as at high risk
of bias for this domain.
Effects of interventions
Data synthesis and meta-analysis were not possible for three rea-
sons:
1. methodological weaknesses in the selected studies;
2. heterogeneity of the outcome measures; and
3. the heterogenous nature of the interventions.
Although data were available of a similar generic type (e.g. severity,
quality of life data), there were insufficient comparative data on
the specific measures used (e.g. severity data from the use of SCO-
RAD). Consequently, we did not undertake the planned assess-
ments of heterogeneity and the subgroup and sensitivity analyses.
We presented a forest plot without a meta-analysis of objective
SCORAD for studies with available data and a narrative analysis
of remaining studies for disease severity and for other outcome
measures.
Primary outcome measures
(i) Participant-rated global assessments
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None of our included studies assessed participant-rated global as-
sessment or the medical practitioner global rating.
(ii) Reduction in disease severity
Follow-up data on objective SCORAD were available from Grillo
2006;Moore 2009; Schuttelaar2010; Shaw2008; andStaab 2006,
either directly from the paper or by contact with the authors, and
are presented in Analysis 1.1; Figure 3. In the interpretation of
the forest plot, it should be borne in mind that follow-up time
for the presented results varied from 1 month (Moore 2009) up
to 12 months (Schuttelaar 2010; Staab 2006). The nature of the
interventions also varied, as described below.
Figure 3. Forest plot of comparison: 1 Intervention versus usual care; outcome: 1.1 Reduction in disease
severity: objective SCORAD
Grillo 2006 evaluated an intensive parental and child education
programme, taking the form of a two-hour workshop. As illus-
trated in Analysis 1.1, scores at follow-up were significantly better
in the intervention group, with a mean difference of -16.7. Addi-
tionally, the analyses presented in the paper that take into account
baseline data demonstrate statistically significant improvements (P
< 0.005) in the intervention group relative to the control group
at both 1 month and 3 months. However, as a cautionary caveat,
the lower 95% confidence limit for the group difference is 6.35,
which is less than the minimum clinically important difference of
8.2 for objective SCORAD.
Moore 2009 evaluated the effect of a nurse-led eczema workshop
as their intervention in comparison to usual care at a dermatolo-
gist-led clinic. Severity of atopic eczema, measured by the SCO-
RAD, was the primary study outcome. Analysis 1.1 illustrates that
the difference in objective SCORAD at follow-up was statistically
significant and in favour of the intervention. Once again, the 95%
confidence interval does not exclude the minimum clinically im-
portant difference of 8.2.
Schuttelaar 2010 evaluated nurse practitioner care as their inter-
vention in comparison to usual care with a dermatologist as the
control. It was hypothesised that nurse practitioner care would be
beneficial because the consultation time was greater and the care
was more structured. Analysis 1.1 illustrates that the mean group
difference of -3.1 on the objective SCORAD at 12-month follow
up was not statistically significant.
Shaw 2008 evaluated an intervention comprising a parental and
child education programme involving an individual session at the
initial study visit and further availability for advice throughout
the study from a specialist atopic dermatitis educator. Analysis
1.1 shows that the mean group difference of 1.37 on objective
SCORAD at follow-up was not statistically significant.
Staab 2006 also evaluated an intervention comprising an educa-
tional programme, involving group training at six sessions once a
week for two hours from a multiprofessional team. For younger
children (3 months to 7 years), the intervention was directed at
parents; for the intermediate age range (8 to 12 years), the inter-
vention was directed at both parents and children; and for older
children (13 to 18 years), the intervention was directed at the
children themselves. Analysis 1.1 illustrates the effect of the inter-
vention combined over all the age groups on objective SCORAD
at 12-month follow up. It can be seen that the mean difference
of -4.30 is statistically significant in favour of the intervention.
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However, both the confidence interval limits of 2.46 and 6.14 are
less than the minimum clinically important difference of 8.2 for
objective SCORAD.
As the study was a large and robust study, we have also reported
the effects for objective SCORAD broken down by age that were
presented in the paper. We obtained these by comparing the 12-
month follow-up data controlling for baseline measurements by
an analysis of covariance (ANCOVA). Again, we found statistically
significant group differences: There was greater improvement in
the intervention group for all age groups, but none of the confi-
dence intervals excludes the minimum clinically important differ-
ence.
Objective severity by age group (Staab 2006):
Age group Group difference in improvement over 12months (in-
tervention minus control) (95% CI)
P value
3 to 7 months 4.2 (1.7 to 6.8) 0.0009
8 to 12 years 6.7 (2.1 to 11.2) 0.005
13 to 18 years 9.9 (4.3 to 15.5) < 0.0001
In the study by Sokel 1993, the dermatologist assessed severity
with ’a scoring sheet showing the front and back of the body
divided into 20 zones of approximately equal area’. A score of 0 to
3 was given for each zone in respect of erythema (redness), surface
damage, and lichenification (thickening); the totalmaximumscore
being 60.
There are two sets of results:
1. percentage body coverage (area); and
2. mean severity score.
We summarised the latter in Table 1.
For body coverage, the paper states a key result as ’no significant
difference in the percentage body area covered for either erythema,
lichenification or surface damage’. Children in the combined hyp-
notherapy and biofeedback groups showed a statistically signifi-
cant difference in the severity of surface damage and lichenifica-
tion compared to the control group at visit 3 (20 weeks) (P = 0.04
and P = 0.02, respectively). We found no significant differences in
erythema. Recalculated P values are marginally different to those
reported in the paper; however, this is unlikely to be clinically sig-
nificant (Table 1).
Niebel 2000 evaluated the effects of two interventions: direct par-
ent education and video education of parents compared to derma-
tological standard treatment as the control. They used the Hanifin
1980, Rajka 1989, and SCORAD (summary scores only) meth-
ods to evaluate severity, measured pre-intervention and at follow-
up after four months, and we summarised their results in Table
2. When controlling for pre-intervention measures by analysis of
covariance, there were statistically significant improvements in the
direct parent education and video education groups relative to the
control group on all severity criteria except pruritus measured by
the Rajka 1989 method.
For the Staab 2002 study, the difference between the severity score
(SCORAD) for each study group was not significant (P = 0.43);
limited statistical details are given, with only the mean decrease
in score per group being specified other than the P value. Because
of the weaknesses in results reporting, we have not tabulated the
results.
The Weber 2008 study measured body surface area with eczema
at baseline but not at follow-up. Pruritus intensity and its effect on
the child’s mood and feeding was measured using a McGill pain
questionnaire adapted by Yosipovitch 2002. At follow-up during
the 24-month period (precise time of follow-up not reported),
references to itch by participants from the intervention group re-
duced from daily to weekly (P = 0.023). The group differences
for the effects of pruritus on mood and feeding were respectively
statistically significant (P = 0.03) and of borderline significance (P
= 0.052).
iii) Improvements in sleep
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The included studies did not assess or record improvement in sleep.
However, the impact on sleep is a component of some severity
measures, such as SCORAD.
(iv) Quality of life of child and parent
In the assessment of a single nurse consultation on quality of life
(Chinn 2002), the parent participants completed the CDLQI, the
IDQOL, and the FDI. We summarised the results in Table 3. No
significant differences between control and intervention groups
were found between baseline and follow-up at 4 and 12 weeks
on the CDQOL and IDQOL measures (P > 0.05). However, the
group difference for the change in FDI score at 4 weeks was of
borderline significance (P = 0.06) in favour of the intervention
group (Chinn 2002).
Staab 2002 used the generic ’Daily life’ measure tomeasure quality
of life experienced by the mothers of children with eczema; it
was stated that there was ’significant improvement in the psychic
and somatic well-being, daily life, joy of life and satisfaction with
medical treatment sub-scales’, although no data are given, nor are
the ’P’ values reported. The validated disease-specific quality of life
questionnaire showed an improvement in the intervention group
regarding a subsection of the questionnaire relating to confidence
in the medical treatment group compared to the control group (P
= 0.016).
The multicentred study by Staab 2006 also used a validated
parental quality of life (of children aged less then 13 years) as a
key outcome measure. They used a 26-item German tool ’Quality
of life of parents of children with atopic dermatitis’ (Von Rueden
1999), which has five subscales:
1. psychosomatic well-being;
2. effects on social life;
3. confidence in medical treatment;
4. emotional coping; and
5. disease acceptance.
Summary results for the primary outcomes reflect the analysis of
covariance (ANCOVA) of parental quality of life at baseline and
12 months, comparing intervention minus no intervention, with
adjustment for baseline scores. We gave details of the intervention
minus no intervention estimates and 95% confidence intervals in
Table 4. Parents of children with eczema aged under seven years
had significantly better improvements in the intervention group
on all five quality of life subscales. Parents of children aged 8 to
12 years experienced significantly better improvements in the in-
tervention group on 3 of the 5 subscales; the changes in psycho-
somatic well-being and effects on social life were not statistically
significant.
Grillo 2006 used three extensively validated measures of quality
of life: IDQOL for children aged < 4 years, CDLQI for children
aged 4 to 16 years, and the Dermatology Family Impact (DFI)
questionnaire. We summarised the results in Table 5. There was
no statistically significant difference between groups at either week
4 or week 12 for the IDQOL and the DFI. For the CDLQI, the
group difference at week 4 was not statistically significant, but at
week 12 it was statistically significant (P < 0.0001).
Weber 2008 used the CDLQI and DFI to evaluate the impact of
attending a series of educational support groups. There was no
significant difference in CDLQI between groups at baseline (P =
0.86). The intervention group showed a significant improvement
relative to the control group at follow-up (P < 0.01). Specifically,
there was evidence of improvement in the quality of life, i.e. leisure
(P = 0.04) and personal relationship (P = 0.02) domains in the
intervention group relative to the control group. There were no
group differences in the DFI scores following the intervention.
Secondary outcome measures
(i) Reduction of harmful scratching behaviour
No studies used this outcome.
(ii) Improvement in treatment adherence
In the Staab 2002 study after the education programme, inflam-
mation of the skin was treated with significantly more steroids by
the intervention group than the control group (P = 0.001), reflect-
ing that adequate quantities were then being used.
Moore 2009 reported greater use of wet dressings in the nurse-led
group (76%) compared with the dermatologist-led clinic (12%).
Post-intervention, 5/49 (10%) nurse-led workshop attendees and
11/50 (22%) dermatologist clinic attendees were bathing twice
daily. Of nurse-led eczema workshop participants, 80% were ap-
plying emollients at least twice daily compared with 62% from the
dermatologist-led clinic. Both groups used comparable strength of
steroid on the face. However, 5/50 (10%) children from the der-
matologist-led clinic were using a potent preparation on their face
compared with 1/49 (2%) from the nurse-led workshop (Moore
2009). More children were treated with antibiotics following ini-
tial consultation with the dermatologist (n = 10, 20%) compared
with the nurse-led (n = 3, 6%) clinics.
(iii) Reduction of medication usage
No studies used this outcome.
(iv) Enhancement of caregiver ability to manage atopic
eczema in the child
No studies used this outcome.
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(v) Cost and inconvenience
Staab 2002 assessed the direct treatment costs covered by pub-
lic health insurance (medical consultations and prescriptions) by
comparing six months prior to the study and one year after. Cost
reduction was significantly greater in the intervention group than
the control group (P = 0.043). There were no reports of inconve-
nience.
D I S C U S S I O N
Summary of main results
The data for this review were limited, comprising 10 studies. Nine
studies focused on parental education interventions (Chinn 2002;
Grillo 2006; Moore 2009; Niebel 2000; Schuttelaar 2010; Shaw
2008; Staab 2002; Staab 2006; Weber 2008), of which nurses de-
livered four interventions (Chinn 2002; Moore 2009; Schuttelaar
2010; Staab 2002), and three were multi-disciplinary delivery
(Staab 2002; Staab 2006; Weber 2008). The Shaw 2008 study
used a senior medical student for intervention delivery, and it is
unclear who delivered the intervention in the Grillo 2006 study.
Only one study of psychological interventions met the inclusion
criteria; this had two relaxation intervention groups: biofeedback
and hypnotherapy (Sokel 1993). All interventions were provided
as an adjunct to conventional topical therapy.Only a limited range
of the psychological interventions available were employed. The
included studies addressed two of our primary outcome measures:
reduction in disease severity and quality of life, but they did not
address the other two: participant-rated global assessment and im-
provement in sleep. The included studies addressed only one of
our secondary measures: improvement in treatment adherence. It
was surprising not to find the use of sleep improvement as an out-
come measure, given the reporting in the literature of sleep dis-
ruption as a significant consequence of childhood atopic eczema
(Emerson 2000). We could not synthesise data from these studies
because of the following factors: the heterogeneous nature of the
outcome measures used, a lack of adequate data (both in quality
and accessibility), and methodological weaknesses in study design.
The evidence available to date is therefore derived from individual
studies.
For parental educational interventions, four studies reported sta-
tistically significant improvements in clinical severity in the in-
tervention groups compared to the control (Grillo 2006; Moore
2009; Niebel 2000; Staab 2006). The Schuttelaar 2010 study re-
ported significant improvements in SCORAD, in both control
(dermatologist) and intervention (nurse) groups. However, qual-
ity of reporting was variable, with Moore 2009 providing limited
information, and Niebel 2000 omitting SCORAD data for the
parental education group. The difference in SCORAD found be-
tween comparison groups was not significant in the Staab 2002
study. One multicentre study found significant impact on SCO-
RAD (Staab 2006). However, we support Williams 2006 obser-
vation that it remains unclear whether the degree of the final dif-
ferences observed between groups could be accounted for by the
differential use of appropriate treatments (individual therapy re-
mained the responsibility of the participants’ doctors). The quality
of reporting of SCORAD scores varied in the included studies.
The Staab 2006 study found statistically significant improvements
in parental quality of life in all 5 subscales for their affected child
within the ’7 years and under’ age group and in 3 of these subscales
for the ’8 to 12 years’ age group.
We found no differences in quality of life outcomes at 4 and 12
weeks in the study by Chinn 2002. One multicentre study found
significant impact on SCORAD (Staab 2006).
The single psychological study (Sokel 1993) identified significant
differences in two of three elements of the multi-dimensional clin-
ical severity score (surface damage and lichenification) between
the intervention groups (biofeedback and hypnotherapy) and the
control group (discussion only) (Sokel 1993).
Overall completeness and applicability of
evidence
We identified no studies that could not be subsequently located.
A small number of studies met the inclusion criteria, employing
a limited range of the potential psychological and educational in-
terventions available. These included educational interventions:
parental (and child), education (nurse- or multi-disciplinary-led),
nurse-led individually, or with groups of participants. They also
included the use of technology to support education (video or
not), relaxation-based psychological interventions, or complemen-
tary interventions (hypnotherapy and biofeedback). Although we
identified a number of relevant studies in terms of the type of in-
tervention, design, and disease outcome measures used, because
the population was made up of adults, we therefore recorded them
as excluded studies, albeit ones of clinical and methodological rel-
evance.
Themainmethodological weaknesses of our included studies were
as follows:
1. unclear allocation concealment in several studies (Chinn
2002; Grillo 2006; Niebel 2000; Sokel 1993; Staab 2002; Weber
2008) due to lack of information from published papers and
correspondence;
2. blinding of the outcome assessor was unclear in four studies
(Grillo 2006; Niebel 2000; Shaw 2008; Weber 2008); in others,
blinding was not possible (Staab 2002) as parents completed
assessment;
3. loss to follow up was problematic in the Shaw 2008; Sokel
1993; and Staab 2002 studies, which had less than 80% follow
up; and
4. finally, although all 10 studies said they used random
allocation, the method by which this was achieved remains
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unclear in four studies (Niebel 2000; Sokel 1993; Staab 2002;
Weber 2008).
Although the majority of these studies used validated outcome
measures, exceptions included Sokel 1993, which used a non-
validated severitymeasure, and Staab 2002, which used an untitled
disease-specific parental quality of life measure and the Trier Scales
of Coping (Staab 2002), which are used widely in German studies.
Moore 2009 reported simply asking participants about changes in
treatment adherence.
Furthermore, although most of the included studies focused on
parental education, there were few parentally-focused outcomes,
other than the use of a parental or a family quality of life measure
in five studies (Grillo 2006; Schuttelaar 2010; Staab 2002; Staab
2006; Weber 2008). It may also be speculated that the clinical
outcomes used to measure the impact of the parentally directed
interventions (that directly related to the child, e.g. clinical sever-
ity) may not have been a sufficiently sensitive measure of effec-
tiveness. The issue of studies being underpowered is highlighted
in the Chinn 2002 study; the estimation of sample size was un-
able to detect a significant change in primary care participants.
There were reporting problems with some of the individual stud-
ies, with key quantitative results not being reported. For example,
the Niebel 2000 study did not present SCORAD summary scores
for the parental education group.
Educational interventions are by their nature complex and, as such,
may interact in a complex way with the organisation of health
services, which are influenced by socioeconomic and cultural fac-
tors. By way of illustration, variations may exist in the availabil-
ity of specialist dermatology care and the staff to deliver these.
Furthermore, the education and scope of practice of health pro-
fessionals and the distribution and delivery of services across pri-
mary and secondary care vary within and between countries. In
addition, educational and psychological interventions represent a
highly heterogeneous grouping of interventions due to the wide
range of methods employed and ways of utilising and delivering
them. The range of psychological interventions that could be po-
tentially employed is high, each with different theoretical under-
pinnings. This is reflected in the intervention summary earlier in
the review. Interestingly, no included studies used ’theoretically
based’ interventions drawing on, for example, behavioural modi-
fication or self-efficacy theory.
The capacity of an outcome measure to detect a clinically sig-
nificant change in a person remains unclear for the primary out-
come measures used in the included studies. The most renowned
severity measure of atopic eczema is SCORAD. This measure has
been validated several times on the basis of establishing good in-
ter-rater judgements and recognising the need for prior training
(Kunz 1997; Pucci 2005), but it has yet to be assessed against
global measures so that it can be correlated with a participant-per-
ceived measure of change. A systematic review of named outcome
measures for atopic eczema found that SCORAD, POEM (Pa-
tient Orientated Eczema Measure), and EASI (Eczema Area and
Severity Index) were the only adequately validated scores (Schmitt
2007).
Adult and child studies compared
A search of the literature on educational and psychological inter-
ventions for adults with eczema using the databases MEDLINE,
CINAHL, and theCochraneDatabase of SystematicReviews from
2000 to 2013 revealed relatively few studies in this area. How-
ever, it is useful to briefly compare child studies to relevant adult
studies because of methodological insights that may be gained
from their discussion and comparison. This may help others when
planning future robust studies in children. Nine of the included
paediatric studies focused on educational interventions, involv-
ing either nurse-led or multi-disciplinary interventions, directed
either at individual parents or groups and located in out-patient
or primary care practices as described (Chinn 2002; Grillo 2006;
Moore 2009; Niebel 2000; Schuttelaar 2010; Shaw 2008; Staab
2002; Staab 2006; Weber 2008).
Four key adult educational studies (Armstrong 2011; Coenraads
2001; Gradwell 2002; Jaspers 2000) involved individual con-
tact (Gradwell 2002), group education (Coenraads 2001; Jaspers
2000), and the use of online video-based education versus the pro-
vision of an educational pamphlet (Armstrong 2011). Two stud-
ies highlighted improvements in clinical severity and improved
self-care ability (Coenraads 2001; Jaspers 2000). Armstrong 2011
demonstrated that knowledge of eczema and disease severity were
both significantly improved in the video group when compared
with the pamphlet group. There was also further evidence of a
reduced need for consultations (Jaspers 2000). Standardised out-
come measures used included the use of severity measures simi-
lar to those used in child studies, such as SCORAD (Coenraads
2001), and quality of life measures including DLQI (Gradwell
2002) and the Short Form (36) Health Survey (SF-36) (Jaspers
2000). Armstrong 2011 used the Patient Oriented Eczema Mea-
sure (POEM).
The adult studies give a clearer indication of effectiveness than
those for the child studies. This would appear to be due to the
improved design and clarity about the stages of the research pro-
cess and in reporting of results, not due to the nature of the inter-
ventions. The rigorously designed adult studies by Gradwell 2002
(educational intervention) and Ehlers 1995 (psychological inter-
vention), in terms of the use of robust outcome measures and con-
trols, may provide useful pointers toward effective study design for
child intervention studies. These studies also highlight the need
to give consideration to the scope for combining educational and
psychological approaches (based on relaxation and habit reversal)
in the management of atopic eczema in children.
Quality of the evidence
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The strength and consistency of evidence available is limited be-
cause of the lack of robust studies with data and design of a similar
nature sufficient to allow data synthesis. The data from individual
studies remain inconclusive in terms of the effectiveness of the
interventions studied given that there is a combination of some
clinically significant results in some outcome measures and no dif-
ferences in others, together with methodological weaknesses in all
studies.
Potential biases in the review process
There were no known biases operating in the review process.
Agreements and disagreements with other
studies or reviews
This is an update of the first Cochrane systematic review to focus
on evaluating the impact of psychological and educational inter-
ventions on children with atopic eczema (Ersser 2007). A Health
Technology Assessment generic review of interventions for atopic
eczema (Hoare 2000) embraced such strategies.
More recent and wide-ranging systematic reviews and meta-anal-
yses of educational and psychological interventions for adults in-
clude patient education in chronic skin disease (de Bes 2011) and
the effectiveness of psychological interventions for adults with skin
conditions (Lavda 2012). de Bes 2011 concluded that patient edu-
cation for adults appears to be effective in improving quality of life
and in reducing perceived severity of skin disease. It is suggested
by Lavda 2012 that whilst psychological interventions are benefi-
cial for people with skin disease, there is a need for more robust
randomised controlled studies and development of a wider range
of interventions developed with a wider range of skin conditions.
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
This review draws on evidence from 10 trials. It is interesting that
the studies focused on interventions directed at the parent rather
than the child, particularly when ’atopic schools’ offering multi-
disciplinary therapeutic patient education, involving both parents
and children, are becomingmore common (Barbarot 2013). Based
on the Chinn 2002; Moore 2009; Niebel 2000; and Schuttelaar
2010 studies, there is limited evidence that parental education de-
livered by nurses who are caring for children with atopic eczema
may improve the clinical severity of the atopic eczema when used
as an adjunct to conventional treatment. Details of the precise
nature of educational activity within nurse-led clinics are limited;
consideration needs to be given to this issue and its reporting. Ev-
idence from the robust GADIS (German Atopic Dermatitis In-
tervention Study) multicentre study (Staab 2006) of multi-disci-
plinary intervention using an eczema school curriculum indicates
that children and their parental carers may benefit from structured
education, albeit using a complex intervention. There appear, in
consequence, to be two main service delivery models - nurse-led
and multi-disciplinary - in operation; however, we have no com-
parative evaluation of their relative effectiveness, either clinically
or in terms of cost. Furthermore, reliable conclusions cannot be
drawn on the effectiveness of psychological and complementary
approaches, namely biofeedback and hypnotherapy, from one sat-
isfactory but small study.
Since the management of atopic eczema requires an adaptation in
health and illness behaviour and effective actions by the carer, it is
logical to develop and evaluate both psychological and educational
strategies as an adjunct to conventional therapy. It is surprising
that despite the wide range of psychological interventions avail-
able, few have been subject to application, and there has been lit-
tle robust evaluation. Educational interventions directed towards
parents also appear to be worthy of development and robust test-
ing, with attention given to finding both effective and resource-
efficient models. Current case-based indications of good practice
in prominent dermatology departments reveal recognition of the
potential of such approaches (e.g. Lawton 2005). Educational in-
terventions require careful consideration of both the content of
learning and of the most effective process, including who is best
placed to teach affected people, at what frequency and duration,
and whether or not educational technology should be employed.
Nine of the 10 RCTs focused on parental education and used a
variety of intervention formats.
An important issue for consideration is the scope and limits of the
application and effectiveness of psychological interventions that
have been used with adults could be used with children and their
parents. The adult studies provide some additional, useful and
relevant information on both interventions and their evaluation,
which was not found within the child studies under review. For
example, although based on small studies, there are indications
that the habit reversal technique used in conjunction with con-
ventional treatment may improve atopic eczema outcomes (Melin
1986; Norén 1989). However, its application to children will de-
pend on the child’s developmental stage. Similarly, Ehlers 1995
showed that although a combined approach (patient education
and cognitive-behavioural treatment) led to a significantly larger
improvement in atopic dermatitis than intensive patient educa-
tion or conventional dermatological treatment, such treatment
will be limited to some older children of the appropriate devel-
opmental stage. In contrast, those educational studies that have
sought to improve effective health behaviour through adult edu-
cation have direct applicability to parental carers of children with
atopic eczema. For example, Gradwell 2002 showed that a single
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20-minute appointment with a nurse to demonstrate the use of
therapies (as well as the standard consultant appointment and fol-
low-up) was useful in improving the participants’ understanding
of the treatments. Therefore, there may be some limited scope to
explore psychological interventions as an additional therapy for
children of the appropriate developmental stage. There may also
be opportunities to apply the interventions used to teach adults
with atopic eczema to the parents of children with atopic eczema.
This review suggests that there is scope for both multi-disciplinary
teams and suitably qualified individual clinicians, such as nurses,
as well as psychologists, to deliver educational interventions in
conjunction with conventional therapy. In some countries, such
as the UK, nurse-led clinics provide an opportunity for focused
intervention. In countries such as Germany, the eczema school
multi-disciplinary model is more established. There is scope to
debate the relative merits of these different service delivery models
that employ suitably qualified professionals to deliver both psy-
chological and educational interventions. There is also scope to
study how educational activity can most effectively be integrated
with the resource efficient provision of conventional dermatolog-
ical therapy.
Implications for research
A relatively small number of studies fulfilled our inclusion criteria,
and of these, we assessed only three as at low risk of bias. As such,
there are significant opportunities to improve research design to
evaluate psychological and educational interventions for children
with atopic eczema and the reporting standards of such studies.
It is important that in the development of future trials, those peo-
ple who will actually use the intervention are involved at an early
stage (Medical ResearchCouncil 2008). Interventions should have
a robust and explicit theoretical base (NICE 2013), and consider-
ation should be given to duration and frequency.
The Harmonising Outcome Measures for Eczema (HOME) ini-
tiative concluded that the core outcomes that all eczema-related
RCTs should report on are clinical signs, symptoms, long-term
control of flares, and quality of life (Schmitt 2012). At theHOME
III meeting (HOME 2013), it was agreed that EASI should be
the instrument for measuring signs of eczema. It is advised that
self-efficacy measures are incorporated particularly as this is likely
to be a key mediator in changing the health behaviour of parents
caring for children with eczema (Ersser 2013). Quality of life, for
both the child and their family, and sleep are also important mea-
sures (HOME2013). Consideration needs to be given to clinically
meaningful time frames for applying selected outcome measures
to assess sustained change.
Useful information to inform the design of more robust trials
may be obtained from this review of existing studies examining
the delivery of psychological and educational interventions to the
parents of children with atopic eczema and those adult studies
discussed above. These include ensuring the following:
1. the use of (and reporting of ) adequate methods of random
allocation and allocation concealment;
2. the use of validated outcome measures (for validity and
reliability, for use with the appropriate populations under study);
and
3. the pursuit of loss to follow up is addressed within the study
design.
In addition, given the nature of the interventions and outcomes
examined in this review, there is scope to consider a wider range of
research designs other than RCTs within any subsequent reviews,
since thesemay help us to better understand the behavioural nature
and effects of educational and psychological interventions.
In conclusion, there is significant scope to undertake intervention
development and then design robust trials to evaluate theoretically
based psychological and educational interventions, which may en-
hance the management of atopic eczema in children.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Chinn 2002
Methods Design: parallel group
Unit of randomisation: the child
Unit of analysis: the child-parent dyad
Participants Setting: primary care (general practice)
Diagnostic criteria: yes, BAD guidelines
Disease severity: children aged 6 months to 5 years, parents rated severity on a ’five point
scale’
Inclusion criteria of the trial
• diagnosis was confirmed by BAD guidelines, new cases, and parents requesting
repeat prescriptions
• 6 months to 16 years old
Participants randomised: 240 in total = 120 (intervention) and 120 (control)
Participants who took part: 235 in total = 115 (intervention) and 120 (control)
Age: 6 months to 4 years (younger group) = 61 (intervention) and 54 (control); 4 years
to 16 years = 58 (intervention) and 62 (control)
Sex: not stated
Duration of condition: new cases and parents requesting repeat prescriptions (interven-
tion and control)
Severity of condition: At baseline, parent completed a ’five-point scale for severity’. The
majority of cases were ’fairly good’ (29%) or ’average’ (43%). 25% of parents reported
their child’s eczema as ’severe’ or ’extremely severe’
Withdrawals
Number of: 1 (intervention) and 4 (control)
Reason for: ’Moved out of the area’ or otherwise withdrawn (intervention and control)
Loss to follow up: 14 (intervention) and 24 (control)
ITT analysis: not stated
Interventions Intervention
Nature: nurse-led parental education consultation
Format: face-to-face session with a trained dermatology nurse
Theoretical basis:
Duration: 30 minutes
Frequency: one-off session
No extant theoretical base
Outcomes 1. Quality of Life using the Children’s Dermatology Life Quality Index (4 to 16 years)
or Infant Dermatitis Quality of Life questionnaire (< 4 years)
2. Family Dermatitis Index
Notes Group comparability at baseline: yes
Conventional topical treatment
Allocation concealment: “I generated a list of subject numbers (1-240??) at the beginning
of the study and those that volunteered were allocated according to this list in the order
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Chinn 2002 (Continued)
each patient returned their baseline questionnaire. I did this independent of the practice
or their nurse. The nurse was informed which group each patient had been assigned and
she then arranged the nurse interview for those in the intervention group”
Funding source: Northern and Yorkshire R&D fund
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Sample Size software generated a computer
random numbers list in blocks of 20
Allocation concealment (selection bias) Unclear risk Therewas nomentionof how the randomi-
sation list was concealed
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk It was not possible to blind participants or
healthcare providers, but the outcome as-
sessor was blinded
Incomplete outcome data (attrition bias)
All outcomes
Low risk There was > 80% follow up
Selective reporting (reporting bias) Low risk The publication reported findings on all
outcomes listed in the Methods section
Other bias High risk Dropouts differed significantly: Yes, the
distribution of baseline IDQOL and FDI
scores differed significantly between those
who returned all questionnaires and drop-
outs. The latter had worse QoL FDI scores
at baseline
Grillo 2006
Methods Design: parallel group
Unit of randomisation: the child
Unit of analysis:
• SCORAD: child
• IDQOL: children under 4 (scored by parents)
• CDLQI: children aged 5 to 16
• DFI: parent
Only 3 dropouts, so statistical comparisons not useful
Participants Setting: not clear where education took place or the follow-up measures, although limi-
tations section refers to data collected from 1 hospital site only
Diagnostic criteria: ’diagnosed by physician’
Disease severity: baseline mean SCORAD, intervention = 50.97 (SD 21.83), control =
47.73 (SD 22.61)
Inclusion criteria of the trial
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Grillo 2006 (Continued)
• paediatric patients diagnosed with AE and their parents
Participants randomised: 61 in total = 32 (intervention) and 29 (control)
Participants who took part: 61 in total = 32 (intervention) and 29 (control)
Age: 38 infants aged < 5 years, 23 children aged 5 + years (intervention/control numbers
not stated)
Sex: 35 boys, 26 girls (intervention/control numbers not stated)
Duration of condition: not stated
Withdrawals
Number of: not stated
Reason for: not stated
Loss to follow up: total of 3 (change of address, not possible to contact them)
ITT analysis: not stated
Interventions Intervention
Nature: parental education workshop
Format: face-to-face session
Theoretical basis: not stated
Duration: 2 hours
Frequency: one-off session
Outcomes 1. Severity of eczema: Scoring Atopic Dermatitis (SCORAD)
2. Quality of life: Children’s Dermatology Life Quality Index (CDLQI) or Infant Der-
matitis Quality of Life Questionnaire (IDQOL) (< 4 years)
3. Family impact: Dermatitis Family Impact Questionnaire (DFI)
Notes Funding source: The study was partially funded by a Flinders Medical Centre Volunteer
Study Award
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk A random number generator was used to
place participants into either the interven-
tion or control group
Allocation concealment (selection bias) Unclear risk Insufficient details were provided
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Blinding was unclear for the outcome as-
sessor. Participants were not blinded
Incomplete outcome data (attrition bias)
All outcomes
Low risk There was > 80% follow up
Selective reporting (reporting bias) Low risk The publication reported findings on all
outcomes listed in the Methods section
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Grillo 2006 (Continued)
Other bias Low risk Results were reported for all outcomes
listed in the Methods section, so there was
low risk of selective outcome reporting bias
Moore 2009
Methods Design: parallel group
Unit of randomisation: the child
Unit of analysis: the child
Participants Setting: dermatology clinic (secondary care implied)
Diagnostic criteria: SCORAD at new referral visit
Disease severity: baseline mean SCORAD, intervention = 38 (SD 11), control = 42 (SD
15)
Inclusion criteria of the trial
• new patients referred to a hospital dermatology clinic
Participants randomised: 165 in total = 80 (intervention) and 85 (control)
Participants who took part: 112 in total = 54 (intervention) and 58 (control)
Mean age (months: SD): intervention 34 (33), control 45 (44)
- 0 to 24 months (n) intervention 27, control 21
- 25 to 144 months (n) intervention 21, control 27
- 145 to 192 months (n) intervention 1, control 2
Sex: intervention men = 30, control men = 24
Duration of condition: mean age of onset (months: SD): intervention = 5 (5) and control
= 9 (16)
Withdrawals
Loss to follow up: 5 (intervention) and 8 (control)
Final number of participants evaluable: intervention = 49, control = 50
ITT analysis: not stated
Interventions Intervention
Nature: nurse-led parental education workshop
Format: face-to-face session
Theoretical base: not stated
Duration: 90 minutes contact time
Frequency: one-off session
Outcomes 1. Severity of eczema: Scoring Atopic Dermatitis (SCORAD)
2. Comparison of treatments used ’at review’
Notes Funding source: not stated
Risk of bias
Bias Authors’ judgement Support for judgement
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Moore 2009 (Continued)
Random sequence generation (selection
bias)
Low risk Clinics were randomised in blocks of 10
using statistical software
Allocation concealment (selection bias) Low risk The clinical epidemiology and biostatistics
unit at the participating hospital prepared
sequentially numbered sealed opaque en-
velopes
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Complete blinding was not possible, but
10 blinded assessments showed good relia-
bility with an independent assessor
Incomplete outcome data (attrition bias)
All outcomes
Low risk There was > 80% follow up
Selective reporting (reporting bias) Low risk The publication reported findings on all
outcomes listed in the Methods section
Other bias Low risk Results were reported for all outcomes
listed in the Methods section, so there was
low risk of selective outcome reporting bias
Niebel 2000
Methods Design: parallel group
Blinding: not explained
Unit of randomisation: the parent
Unit of analysis: the child-parent dyad
Participants Setting: dermatology clinic (secondary)
Diagnostic criteria: yes (Hanifin 1980)
Disease severity: medium to severe level of AE
Inclusion criteria of the trial
• none
Participants randomised: 47 in total = 14 (control), 18 (intervention 1), and 15 (inter-
vention 2)
Age ranges not stated in paper
Mean age: children = 3 yrs (control), 4.7 yrs (intervention 1), and 4 yrs (intervention 2)
Sex: 8 M, 6 F (control); 12 M, 6 F (intervention 1); and 8 M, 7 F (intervention 2)
Mean duration of condition: 1.58 yrs (control), 1.6 yrs (intervention 1), and 1.25 yrs
(intervention 2)
Severity of condition: SCORAD baseline = 4 (control), 3.9 (intervention 1), and 4.2
(intervention 2)
Withdrawals
N/A
Loss to follow up: no dropouts from study
Dropouts differed significantly: N/A
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Niebel 2000 (Continued)
Interventions Intervention 1
Nature: parental educational training program delivered in groups (details given of the
topic content)
Format: nurse-led sessions on theoretical and practical information
Theoretical basis:
Frequency: 10 X 2-hr sessions
Duration: maximum of 16 weeks
Intervention 2
Nature: parental educational training program
Format: video film (100 minutes) and booklet with information on theoretical and
practical information
Theoretical basis: theory element and practical element, designed to promote more
therapeutically effective self-help
Frequency duration: maximum 16 weeks
Control group: conventional dermatology consultation with no other intervention
Outcomes 1. Disease severity (SCORAD-summary scores given only). Timing: pre- and post-
assessment
2. Psychological problems with mothers
Notes Group comparability at baseline: The parents’ (mothers’) age and sociodemographic
features were comparable (except for level of school education). Children, comparable
age and severity distribution across groups
Conventional topical treatment: For both groups, when an exacerbation occurred, topical
steroids were used for approximately 1 week. Wet lesions were treated with antiseptic
compressions
Funding source: Ministerium für Arbeit, Soziales, Jugend und Gesundheit des Landes
Schleswig-Holstein
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Randomisation was stated in the text, but
the method was not explained
Allocation concealment (selection bias) Unclear risk Allocation concealment was not explained
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk The process was not explained
Incomplete outcome data (attrition bias)
All outcomes
Low risk There was > 80% follow up
Selective reporting (reporting bias) Low risk The publication reported findings on all
outcomes listed in the Methods section
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Niebel 2000 (Continued)
Other bias Low risk Results were reported for all outcomes
listed in the Methods section, so there was
low risk of selective outcome reporting bias
Schuttelaar 2010
Methods Design: parallel group
Unit of randomisation: the parent
Unit of analysis: the child-parent dyad
Participants Setting: dermatology clinic (secondary)
Diagnostic criteria: yes
Disease severity: mean SCORAD at baseline, control = 31.6, intervention = 34.3
Inclusion criteria of the trial
• new referrals to outpatient with diagnosis of atopic dermatitis
Participants randomised: 160 in total = 81 (nurse practitioner (NP) group), 79 (derma-
tologist (D)) group
Age ranges: 0 to 16 years
Mean age: ≤ 4, NP = 1.5 years, D = 1.6 years; 4 to 16, NP = 9.1 years, D = 9.3 years
Sex: ≤ 4, NP = 30 male, 10 female, D = 29 male, 11 female; 4 to 16, NP = 20 male, 21
female, D = 19 male, 20 female
Mean duration of condition: not stated
Interventions Intervention 1
Nature: parental educational, individual +/- group
Format: nurse-led sessions with theoretical and practical input including treatment of
eczema, practical demonstrations, education, and support
Theoretical basis: social cognitive theory
Frequency: 1 individual session with follow-up in person or by telephone +/- group
session
Duration: individual session 1. 30 minutes, 2. 20 minutes in person or 10-minute
telephone consultation. Group session 2 hours with a maximum of 8 parents
Control group: conventional consultation with dermatologist, no other intervention
Outcomes 1. Child quality of life (IDQOL, CDLQI) at 4, 8, and 12 months
2. Family quality of life (DFI) at 4, 8, and 12 months
3. Severity of eczema SCORAD at 4, 8, and 12 months
4. Participant satisfaction (CSQ-8) at 4, 8, and 12 months
Notes Funding source: This study was supported by the Healthcare Efficiency Research Pro-
gramme of the University Medical Center Groningen, Groningen, the Netherlands
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk A computer-generated randomisation
scheme was used
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Schuttelaar 2010 (Continued)
Allocation concealment (selection bias) Low risk Participants opened consecutive closed en-
velopes
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk It was not possible to blind participants or
healthcare providers, but the outcome as-
sessor was blinded
Incomplete outcome data (attrition bias)
All outcomes
Low risk 95% of participants were followed up
Selective reporting (reporting bias) Low risk The publication reported findings on all
outcomes listed in the Methods section
Other bias Low risk Results were reported for all outcomes
listed in the Methods section, so there was
low risk of selective outcome reporting bias
Shaw 2008
Methods Design: parallel group
Unit of randomisation: the parent
Unit of analysis: the child-parent dyad
Participants Setting: dermatology clinic (secondary care)
Diagnostic criteria: referral to hospital clinic, no criteria used
Disease severity: not stated
Inclusion criteria of the trial
• none
Participants randomised: 151 in total = 74 (control) and 77 (intervention)
Age ranges: newborn to 18 years
Mean age: children = 4.62 (control) and intervention (6.34)
Sex: control men = 25, control women = 27, intervention men = 21, intervention women
= 29
Mean duration of condition: not stated
Severity of condition: SCORAD baseline, control mean = 32.02, intervention = 33.54
Withdrawals
N/A
Interventions Intervention
Nature: parental education, 15-minute individual session following outpatient appoint-
ment, given verbal and written information training programme delivered in groups
(outline given of the topic content)
Format: senior medical student-led session giving theoretical and practical information
Theoretical basis: not stated
Frequency: 1 x 15-minute session
Duration: once only, but telephone and email support available post-session
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Shaw 2008 (Continued)
Outcomes 1. Child quality of life (IDQOL, CDLQI)
2. Disease severity
Notes Funding source: The Doris Duke Clinical Research Fellowship Program
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk A random number generator in Microsoft
Excel was used
Allocation concealment (selection bias) Low risk The caregiver opened sealed envelopes
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk It was not possible to blind the parents or
educator; it was not clear if the outcome
assessor was blinded
Incomplete outcome data (attrition bias)
All outcomes
High risk 70% of complete data were analysed
Selective reporting (reporting bias) Low risk The publication reported findings on all
outcomes listed in the Methods section
Other bias Low risk Results were reported for all outcomes
listed in the Methods section, so there was
low risk of selective outcome reporting bias
Sokel 1993
Methods Design: parallel group
Unit of randomisation: the child
Unit of analysis: the child
Participants Setting: unclear
Diagnostic criteria: no, but ’all had AE that was inadequately controlled’
Disease severity: not for recruitment standardisation, only as an outcome measure
Inclusion criteria of the trial
• children with inadequately controlled atopic eczema (despite the use of
emollients, topical corticosteroids, paste bandages, or antihistamines); however, the age
range for inclusion was not explicitly stated. Informed consent was obtained via the
parent of the child
Participants randomised: 44 in total = 16 (C), 18 (I1), and 10 (I2)
Mean age (months): 117.25 (C), 111.38 (I1), and 108.8 (I2)
Sex: 8 M, 8 F (C); 9 M, 9 F (I1); and 6 M, 4 F (I2)
Duration of condition: not specified
Severity of condition: not specified
Withdrawals
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Sokel 1993 (Continued)
Number of: 12 in total (6 = C)
Reason for: not stated
ITT analysis: not stated
Interventions Intervention 1
Nature: relaxation technique: hypnotherapy
Format: focused specifically on reducing itching through guided imagery, face-to-face
with a clinical psychologist
Theoretical basis: precise technique based onKarle&Boys (1987) andOlness&Gardner
(1988)
Duration: 30-minute sessions
Frequency: 4 sessions at 2, 3, 5, and 8 weeks after enrolment
Intervention 2
Nature: relaxation technique: biofeedback
Format: A relaxometer gave feedback to participants about their level of relaxation using
skin conductance
Theoretical basis: Biofeedback techniques can engage the participant to actively manage
the stress-response initiated by anxiety about their health problem
Duration: 30-minute sessions
Frequency: 4 sessions at 2, 3, 5, and 8 weeks after enrolment
Discussion-only group (control):
Children were encouraged to keep an eczema diary that would be discussed at the
next session. Parents were encouraged to help the children complete this. No specific
psychological therapy was given
Duration: 30-minute sessions
Frequency: 4 sessions at 2, 3, 5, and 8 weeks after enrolment
Outcomes 1. Mean per cent of body coverage for (i) erythema, (ii) surface damage, and (iii) licheni-
fication
2. Mean severity score for (i) erythema, (ii) surface damage, and (iii) lichenification
Notes Group comparability at baseline: yes, no differences between the 3 groups for age or
vocabulary test at enrolment
Conventional topical treatment: All participants were stabilised on conventional topical
and oral treatments for 2 weeks before being randomly allocated to 1 of the groups
Funding source: The Lowe-Costello fund
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk The paper stated a randomised trial, but
the method was not explained
Allocation concealment (selection bias) Unclear risk The process was not explained
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Participants and clinicians were not
blinded, but the outcome assessor was
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Sokel 1993 (Continued)
Incomplete outcome data (attrition bias)
All outcomes
High risk Loss to follow up: There were substantial
missing data and no ITT analysis
Dropouts differed significantly: There were
13 dropouts from the 44 initial partici-
pants, but no reasons were offered within
the paper. No intention-to-treat analysis
was performed, so it is not clear what affect
the high number of dropouts had on the
results
Selective reporting (reporting bias) Low risk The publication reported findings on all
outcomes listed in the Methods section
Other bias Low risk Results were reported for all outcomes
listed in the Methods section, so there was
low risk of selective outcome reporting bias
Staab 2002
Methods Design: parallel group design
Unit of randomisation: the child
Unit of analysis: the child-parent dyad
Participants Setting: secondary-care evening sessions
Diagnostic criteria: yes (Hanifin 1980)
Age range: 5 months to 12 years
Disease severity: Participants had moderate to severe symptoms (SCORAD scale > 20
points)
Inclusion criteria of the trial
• the physician confirmed diagnosis and severity of atopic dermatitis. Participants
were to have a SCORAD scale > 20 points and duration of at least 4 months
Participants randomised: 204 in total = 93 (intervention) and 111 (control)
Mean age: child 2.7 yrs (treatment group) and child 3.4 yrs (control group)
Sex: not stated
Duration of condition: 2.1 yrs (intervention group) and 2.4 yrs (control group)
Severity of condition: SCORAD 44 SD +/- 17 (intervention group) and 42 SD +/- 15
(control group)
Withdrawals
Number of: not stated
Reason for: not stated
Number lost to follow up: 21 (control) and 38 (intervention)
ITT analysis: not stated
Interventions Intervention
Nature: parental educational training program
Format: group sessions with presentations from various experts
Theoretical basis:
Frequency: once a week and for 2 hours in an evening session
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Staab 2002 (Continued)
Duration: 6 weeks
Outcomes Primary outcomes:
1. Disease severity (SCORAD - NB: does not distinguish between objective and subjec-
tive scores)
2. Disease-specific (atopic eczema) parental QoL (untitled)
3. Generic parental QoL (Daily Life Questionnaire)
4. Coping strategies (Trier Scales of Coping)
Secondary outcomes:
1. Questionnaire (unspecified), 2 key items: (1) treatment behaviour - regularity of use
of skin medication (topical steroids) and help seeking from unconventional treatments
(indoor allergy reduction) (and initiated dietary restrictions); (2) direct cost of treatment
- calculated costs for previous 6 months and after 1 year
Notes Group comparability at baseline: yes
Conventional topical treatment
Allocation concealment: The families in this study were randomly assigned to education
or waiting control group. We did not stratify for age or severity. They were enrolled in
the randomisation program in the computer by the time of their first evaluation visit.
After this visit, they were told in what group they had been allocated
Funding source: German Federal Ministry of Education, Science, Research and Tech-
nology (no. 01EG9523)
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk The process was not explained
Allocation concealment (selection bias) Unclear risk The process was not explained
Blinding of outcome assessment (detection
bias)
All outcomes
High risk Blinding was not possible as most out-
come measures were obtained from ques-
tionnaires completed by the families who
were aware of the group to which they were
assigned
Incomplete outcome data (attrition bias)
All outcomes
High risk 77% of the intervention group and 66% of
the control group were followed up
Selective reporting (reporting bias) Low risk The publication reported findings on all
outcomes listed in the Methods section
Other bias Low risk Results were reported for all outcomes
listed in the Methods section, so there was
low risk of selective outcome reporting bias
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Staab 2006
Methods Design: parallel group design
Unit of randomisation: child
Unit of analysis: child-parent dyad
Participants Setting: 7 centres (hospital out-patients) = 3 from children’s hospitals, 3 from hospitals
specialising in dermatology, and 1 from the Department of Psychosomatic Medicine
Diagnostic criteria: yes (Hanifin 1980)
Disease severity: eczema duration, minimum of 3 months, and severity of =/> 20 points
on SCORAD
Inclusion criteria of the trial
• children/young people aged 3 months to 18 years in 3 age bands (< 7 years, 8 to
12, 13 to 18 years), diagnosed by dermatologist or paediatrician
Participants randomised: 992, with 496 allocated to each group (645 in the < 7 band;
214 in the 8 to 12 band; and 151 in the 13 to 18 band)
Mean age (SD): < 7 band = I group: 2.4 (1.8), C group: 2.4 (1.9); 8 to 12 band = I
group: 9.5 (1.6), C group: 9.5 (1.5); 13 to 18 band = I group: 14.9 (1.7), C group: 14.
8 (1.7)
Sex (per cent male): < 7 band = both groups: 52; 8 to 12 band = I group: (40), C group:
(48); 13 to 18 band = I group: (41), C group: (36)
Condition (duration): not specified other than minimum of 3 months
Withdrawls
Loss to follow up: 169 (I = 50, C = 119)
Reasons: tabulated, most gave ’no sufficient response’
Interventions Intervention
Nature: standardised (structured) educational programme delivered by a multiprofes-
sional team (dermatologists, paediatricians, psychologists, dieticians) who had under-
gone 40 hours of training
Format: The content and structure of the programme and teaching methods were agreed
by an interdisciplinary consensus group. Parents of children aged 8 to 12 attended
separate sessions. Adolescents aged 13 to 18 attended tailored sessions. A manual and
handouts were used. NB: did not contain a therapy mandate, remained responsibility of
patients’ doctors
Theoretical basis: not specified
Duration: 6 once-weekly sessions lasting 2 hours each
Control conditions: no education
Outcomes 1. Severity of eczema:
i) SCORAD
ii) subjective severity score (the ’Skin detective’ tool)
iii) Itch questionnaires: used 2 standardised tools (abbreviations only given in paper):
JUCKKI 15-item tool for 8 to 12 age group and JUCKJU of 18 items for the 13 to 18
group
2. Quality of life of parents of children aged < 13 years: Tool (German): ’Quality of
life in parents of children with AD’. 26-item validated tool structured by factor analysis
into 5 subscales (with abbreviations): psychosomatic well-being (pw); well-being (w);
effects on social life (esl); confidence in medical treatment (cmt); emotional coping (ec)
; acceptance of disease (aod)
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Staab 2006 (Continued)
Notes Also known as the GADIS trial
Group comparability at baseline: Yes. In all age groups the severity of eczema or parental
quality of life (of children aged < 13 years) did not differ significantly between the
intervention and control groups at baseline
Funding source: German Federal Ministry of Health and Social Services (grant No
01GL0010)
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk An independent study centre provided
computer-generated random numbers
Allocation concealment (selection bias) Low risk Allocation was concealed in closed en-
velopes
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Blinding was not possible for participants
who provided most of the outcome data
from questionnaires used. The scoring of
the AD severity scale involved staff not in-
volved in intervention
Incomplete outcome data (attrition bias)
All outcomes
Low risk No ITT analysis was undertaken, but over-
all follow-up rates of 83% met the re-
view threshold (a good rate for a long-term
study). The dropout rate was 17% (10% in
the I group, 24% in the C group). There
were twice asmany losses to followup in the
control arm than the intervention group
Selective reporting (reporting bias) Low risk The publication reported findings on all
outcomes listed in the Methods section
Other bias Low risk Results were reported for all outcomes
listed in the Methods section, so there was
low risk of selective outcome reporting bias
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Weber 2008
Methods Design: parallel group design
Unit of randomisation: child-parent dyad
Unit of analysis:
• CDLQI: child
• FDI: child
• Pruritus: child
Participants Setting: not stated
Diagnostic criteria: yes (Hanifin 1980)
Disease severity: AD defined by Hanifin and Rajka’s 21 criteria as moderate or severe
and that did not respond appropriately to conventional treatment
Inclusion criteria of the trial
• children aged 2 to 16 meeting clinical criteria (see above)
Participants randomised: 36
Participants who took part: 36
Age: average intervention = 79.31 +/- 49.82 months and control = 79.44 +/- 53.86
months
Sex: intervention men = 11 and women = 5, control men = 7 and women = 9
Duration of condition: average intervention = 61.25 +/- 42.84 months and control =
56.25 +/- 51.59 months
Withdrawals
Number of: 32/36 completed the follow-up over a 24-month period
Loss to follow up: 4 (reasons not stated)
ITT analysis: not stated
Interventions Intervention
Nature: children’s group meetings (co-ordinated by child psychiatrist and volunteers,
education and play)
Parents’ group meetings (co-ordinated by dermatologists education and discussion)
Format: face-to-face sessions
Theoretical basis: not stated
Duration: 90 minutes
Frequency: fortnightly meetings for 6 months (minimum 75% audience)
Outcomes 1. Quality of life: CDLQI
2. Family impact: Family Dermatitis Impact questionnaire
3. Pruritus: based on the McGill pain questionnaire, adapted from Yosipovitch 2002
Notes Funding source: not stated
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Insufficient information was provided
Allocation concealment (selection bias) Unclear risk Insufficient information was provided
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Weber 2008 (Continued)
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Insufficient information was provided
Incomplete outcome data (attrition bias)
All outcomes
Low risk There was > 80% follow up
Selective reporting (reporting bias) Low risk The publication reported findings on all
outcomes listed in the Methods section
Other bias Low risk Results were reported for all outcomes
listed in the Methods section, so there was
low risk of selective outcome reporting bias
Legend: Gender: F = female, M = male; QoL = quality of life; Age: Yr = year; LFU = loss to follow up; ITT = intention-to-treat analysis;
Study groups: C = control, I = intervention; CI = confidence interval; BAD = British Association of Dermatologists; Outcome
measures: IDQOL = Infant Dermatitis Quality of life Index, CDLQI = Children’s Dermatology Life Quality Index, FDI = Family
Dermatitis Index, DFI = Dermatitis Family Impact questionnaire, SCORAD = Scoring Index of Atopic Dermatitis, CSQ-8 Client
Satisfaction Questionnnare-8; N/A = not applicable; SD = standard deviation; R&D = research and development; AE = atopic
eczema; AD = atopic dermatitis.
References: Hanifin & Rajka (1980), Kardoff & Schnelle-Parker (2001), Karle & Boys (1987), Olness & Gardner (1988), Yosipovitch
(2002).
Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Bae 2012 The trial included adult participants (RCT) with an age range of 12 to 40 and a mean age of 23.5 years,
which was not stated in the abstract
Broberg 1990 Inadequate randomisation was the reason for exclusion
Greene 1997 On obtaining unpublished data, we discovered that the participants were adults
Kardorff 2003 Inadequate randomisation was the reason for exclusion
van Os-Mendendorp 2012 Aggregated child and adult data were presented. We contacted the author who advised that it was not
possible to provide child-only data
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Characteristics of studies awaiting assessment [ordered by study ID]
Futamura 2013
Methods RCT
Participants Mothers of 59 children
Interventions Parental education programme on childhood AD
Outcomes 1. Participants in the intervention group had a significantly lower SCORAD and objective SCORAD score than the
control group at 6 months
2. Sleeplessness symptom score and corticosteroid score in the intervention group were significantly better than those
in the control group at 6 months
There was no significant difference in medication use or quality of life
Notes -
Characteristics of ongoing studies [ordered by study ID]
ISRCTN98560867
Trial name or title Supporting parents’ and carers’ management of childhood eczema (SPaCE)
Methods RCT
Participants Carers of children aged 5 years or less with a diagnosis of eczema on their GP record
Interventions LifeGuide, internet-based behavioural intervention
Outcomes 1. Dermatitis Family Impact questionnaire
2. Infants’ Dermatology Quality of Life index
3. Patient Oriented Outcome Measure
Starting date March 2011
Contact information Dr Miriam Santer
Primary Care Medical Aldermoor Health Centre
Aldermoor Close
Southampton, UK
m.santer@soton.ac.uk
Notes Recruitment completed
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N0060047013
Trial name or title Atopic eczema and Habit Reversal
Methods -
Participants Severe atopic patients
Interventions Behavioural therapy versus conventional medical management
Outcomes 1. Subjective and objective clinical improvement according to benchmarked disease severity indices
Starting date After correspondence with the author, we found that the study is currently discontinued
Contact information Dr Richard CD Staughton
Dermatology Department
Chelsea & Westminster Hospital
369 Fulham Road
London
SW10 9NH
Telephone: 0181 746 8170
richard.staughton@chelwest.nhs.uk or sharon.singh@chelwest.nhs.uk
Notes Does habit reversal programme alter natural history of atopic dermatitis? Is this measurable in blood and skin
samples?
NCT01138761
Trial name or title Health literacy for children with atopic dermatitis and their caregivers
Methods -
Participants 60 children
Interventions Behavioural nurse instruction
Outcomes -
Starting date June 2010
Contact information -
Notes Reported as active, not recruiting
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NCT01143012
Trial name or title Group Eczema Education Visits: Impact on Patient and Family Quality of Life
Methods RCT
Participants Parents of 60 children aged 2 months to 6 years with diagnosis of atopic dermatitis
Interventions Group eczema education session
Outcomes 1.Difference between 2 groups inChildhoodAtopicDermatitis Impact Scale (CADIS) score. Average number
of follow-up telephone calls
Starting date May 2010
Contact information Susan Tofte
Oregon Health and Science University
toftes@ohsu.edu
Notes Register refreshed 17.10.12; trial still recruiting
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D A T A A N D A N A L Y S E S
Comparison 1. Intervention versus usual care
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Reduction in disease severity:
objective SCORAD
5 Mean Difference (IV, Fixed, 95% CI) Totals not selected
Analysis 1.1. Comparison 1 Intervention versus usual care, Outcome 1 Reduction in disease severity:
objective SCORAD.
Review: Psychological and educational interventions for atopic eczema in children
Comparison: 1 Intervention versus usual care
Outcome: 1 Reduction in disease severity: objective SCORAD
Study or subgroup Intervention Usual care
Mean
Difference
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Grillo 2006 30 23.52 (16.53) 28 40.21 (22.9) -16.69 [ -27.03, -6.35 ]
Moore 2009 49 10.53 (6.85) 50 18.44 (10.09) -7.91 [ -11.30, -4.52 ]
Schuttelaar 2010 73 19 (11) 70 22.1 (11.9) -3.10 [ -6.86, 0.66 ]
Shaw 2008 50 15.82 (11.28) 49 14.45 (9.61) 1.37 [ -2.76, 5.50 ]
Staab 2006 446 20 (13.79) 377 24.3 (13.07) -4.30 [ -6.14, -2.46 ]
-20 -10 0 10 20
Favours intervention Favours usual care
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A D D I T I O N A L T A B L E S
Table 1. Mean severity scores: children completing 3 assessment sessions (Sokel 1993)
Severity dimension Combined intervention groups - control
(Biofeedback and hypnotherapy) - (discussion)
(95% CI)
P value
(A) Erythema
8 weeks -2.2 (-9.58, 5.18) 0.551
20 weeks -8.2 (-17.2, 0.78) 0.072
(B) Surface damage
8 weeks -1.2 (-8.32, 5.92) 0.735
20 weeks -8.3 (-16.2, -0.41) 0.040
(C) Lichenification
8 weeks -1.0 (-7.60, 5.60) 0.761
20 weeks -8.8 (-16.0, -1.55) 0.019
CI = confidence interval
Table 2. Childrens’ skin condition (severity) after dermatology consultation (Niebel 2000)
Severity
score
DE (pre) DE (post) VE (pre) VE (post) Control
(pre)
Control
(post)
ANOVA/
ANCOVA
P value
Ra-
jka & Lan-
geland crite-
ria
1. General
severity
3.9 (SD 1.
19)
3.2 (SD 1.
47)
4.2 (SD 0.
94)
3 (SD 1.25) 4 (SD 1.1) 3.71 (SD 2.
43)
Z:F (1/36) =
5.76
P < 0.022
2. Surface
area
1.9 (SD 0.
88)
1.7 (SD 0.
82)
2 (SD 0.53) 1.47 (SD 0.
64)
1.71 (SD 0.
61)
1.36 (SD 0.
63)
Z:F (1/36) =
10.87
P < 0.002
3. Pruritus 2 (SD 0.67) 1.5 (SD 0.
71)
2.2 (SD 0.
56)
1.53 (SD 0.
64)
2.29 (SD 0.
61)
2.36 (SD 2.
34)
Z:F (1/36) =
2.09
P < 0.15
Hanifin cri-
teria
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Table 2. Childrens’ skin condition (severity) after dermatology consultation (Niebel 2000) (Continued)
1. Erythema 1 (SD 0.65) 0.58 (SD 0.
61)
2.4 (SD 0.
66)
1.53 (SD 1.
06)
1.71 (SD 0.
8)
1.36 (SD 1.
15)
Z:F (1/39) =
11.34
P < 0.002
2. Excoria-
tion
1.61 (SD 0.
98)
0.65 (SD 0.
85)
2.13 (SD 0.
95)
1.3 (SD 1.
06)
1.86 (SD 0.
95)
1.07 (SD 1.
21)
Z:F (1/39) =
15.6
P < 0.0001
3. Lichenifi-
cation
1.54 (SD 0.
96)
0.75 (SD 0.
84)
2.27 (SD 0.
96)
2 (SD 1.25) 2.14 (SD 0.
86)
1.86 (SD 1.
03)
Z:F (1/38) =
7.12
P < 0.01
4. Flaking 1.73 (SD 0.
83)
1.04 (SD 0.
9)
1.57 (SD 0.
75)
1.3 (SD 0.
98)
2.07 (SD 0.
92)
1.77 (SD 0.
96)
Z:F (1/39) =
5.73
P < 0.022
5.
Induration
0.83 (SD 0.
94)
0.42 (SD 0.
7)
1.7 (SD 0.
78)
0.93 (SD 1.
16)
1.11 (SD 1.
08)
0.68 (SD 0.
72)
Z:F (1/38) =
14.48
P < 0.0001
6. Inflam-
mation
1.13 (SD 0.
86)
0.5 (SD 0.
56)
1.53 (SD 1.
13)
0.67 (SD 1.
13)
0.93 (SD 0.
99)
0.29 (SD 0.
61)
Z:F (1/38) =
13.48
P < 0.001
SCORAD
(summary)
N/A N/A 55.91 (18.
45)
36.91 (25.
95)
48.66 (SD
15.43)
32.33 (SD
17.75)
Z:F (1/27) =
22.42
P < 0.0001
DE = Direkte ElternSchulung (direct parent education)
VE = Video ElternSchulung (video education of parents)
Control = dermatological standard treatment
pre = prior to the intervention
post = at follow-up after 4 months
SCORAD = Scoring Index of Atopic Dermatitis
Analysis of variance (ANOVA)
Analysis of covariance (ANCOVA)
Table 3. Change in quality of life scores across comparison groups (Chinn 2002)
QoL measure Group difference
(Intervention - control)
(95% CI)
P value
(A) CDLQI
Baseline - 4 weeks -1.3 (-3.2 to 0.6) 0.17
Baseline - 12 weeks 0.24 (-1.5 to 2.0) 0.7
(B) IDQOL
Baseline - 4 weeks -0.05 (-1.3 to 1.2) 0.9
Baseline - 12 weeks 1.2 (-0.8 to 3.1) 0.24
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Table 3. Change in quality of life scores across comparison groups (Chinn 2002) (Continued)
(C) FDI
Baseline - 4 weeks -0.79 (-1.62 to 0.04) 0.06
Baseline - 12 weeks 0.34 (-0.8 to 1.5) 0.5
QoL = quality of life
CDLQI = Children’s Dermatology Life Quality Index
IDQOL = Infant Dermatitis Quality of life Index
FDI = Family Dermatitis Index
CI = confidence interval
Table 4. Parental QoL by age group using ANCOVA (Staab 2006)
Outcome by age group Group difference
(Intervention - control)
(95% CI)
P value
*3 months to 7 years*
Psychosomatic well-being -1.4 (-2.5 to -0.2) 0.0040
Effects on social life -0.8 (-1.4 to -0.2) < 0.0001
Confidence on medical treatment -2.1 (-2.8 to -1.4) < 0.0001
Emotional coping -1.9 (-2.5 to -1.3) < 0.0001
Acceptance of disease -0.6 (-0.9 to -0.2) < 0.0001
*8 to 12 years*
Psychosomatic well-being -0.6 (-2.4 to 1.2) 0.360
Effects on social life -0.2 (-1.2 to 0.8) 0.940
Confidence on medical treatment -2.9 (-4.1 to -1.7) < 0.0001
Emotional coping -1.8 (-2.8 to -0.9) 0.002
Acceptance of disease -0.6 (-1.2 to 0) 0.031
CI = confidence interval
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Table 5. Difference in quality of life scores at weeks 4 and 12 (Grillo 2006)
QoL measure Group difference
(Intervention - control)
(95% CI)
P value
(A) CLDQI
Week 4 -1.79 (-4.00, 0.42) 0.110
Week 12 -5.33 (-7.04 to -3.62) < 0.0001
(B) IDQOL
Week 4 2.10 (-0.87 to 5.07) 0.162
Week 12 1.58 (-0.612 to 3.77) 0.154
(C) DFI
Week 4 0.27 (-3.38 to 3.92) 0.883
Week 12 -0.42 (-3.48 to 2.64) 0.785
QoL = quality of life
CDLQI = Children’s Dermatology Life Quality Index
IDQOL = Infant Dermatitis Quality of life Index
DFI = Dermatitis Family Impact questionnaire
CI = confidence interval
A P P E N D I C E S
Appendix 1. Cochrane Skin Group Specialised Register search strategy
(eczema or dermatitis or neurodermatitis) and (psychotherap* or “behavio* management” or autogenic or counsel* or hypnosis or
hypnotherapy or relaxation or “psychotherapeutic technique*” or “self help” or mindfulness or imagery or biofeedback or “health
promotion” or education or “patient teaching” or “patient training” or psychology or psychiatry or ((psychodynamic or cognitive or
famil* or behavio*) and therap*))
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Appendix 2. CENTRAL (Cochrane Library) search strategy
#1 MeSH descriptor Eczema explode all trees
#2 MeSH descriptor Dermatitis, Atopic explode all trees
#3 MeSH descriptor Neurodermatitis explode all trees
#4 MeSH descriptor Dermatitis explode all trees
#5 (eczema or dermatitis or neurodermatitis):ti,ab,kw
#6 (#1 OR #2 OR #3 OR #4 OR #5)
#7 MeSH descriptor Psychotherapy explode all trees
#8 MeSH descriptor Patient Education as Topic explode all trees
#9 MeSH descriptor Education explode all trees
#10 MeSH descriptor Health Education explode all trees
#11 MeSH descriptor Psychology explode all trees
#12 MeSH descriptor Behavior Therapy explode all trees
#13 MeSH descriptor Cognitive Therapy explode all trees
#14 MeSH descriptor Autogenic Training explode all trees
#15 MeSH descriptor Suggestion explode all trees
#16 MeSH descriptor Hypnosis explode all trees
#17 MeSH descriptor Counseling explode all trees
#18 MeSH descriptor Relaxation explode all trees
#19 MeSH descriptor Relaxation Therapy explode all trees
#20 MeSH descriptor Imagery (Psychotherapy) explode all trees
#21 MeSH descriptor Biofeedback, Psychology explode all trees
#22 MeSH descriptor Family Therapy explode all trees
#23 MeSH descriptor Health Promotion explode all trees
#24 MeSH descriptor Parent-Child Relations explode all trees
#25 MeSH descriptor Skin Care explode all trees
#26 MeSH descriptor Self-Help Groups explode all trees
#27 MeSH descriptor Psychiatry explode all trees
#28 (psychodynamic therap*) or (behavio* management) or (behavio* therapy) or (autogenic training) or (counsel*)
#29 (psychotherapy) or (suggestion):ti,ab,kw or (hypnosis or hypnotherapy) or (cognitive therap*) or (relaxation)
#30 (psychotherapeutic technique*) or (self help) or (support):ti,ab,kw or (mindfulness or imagery or biofeedback ) or (family therap*)
#31 (health promotion) or (health education) or (patient education) or (patient teaching) or (patient training)
#32 (#7 OR #8 OR #9 OR #10 OR #11 OR #12 OR #13 OR #14 OR #15 OR #16 OR #17 OR #18 OR #19 OR #20 OR #21 OR
#22 OR #23 OR #24 OR #25 OR #26 OR #27 OR #28 OR #29 OR #30 OR #31)
#33 (#6 AND #32)
Appendix 3. MEDLINE (OVID) search strategy
1. exp Eczema/ or eczema.mp.
2. exp Dermatitis, Atopic/
3. neurodermatitis.mp. or exp Neurodermatitis/
4. exp Dermatitis/ or dermatitis.mp.
5. or/1-4
6. exp Psychotherapy/
7. exp Patient Education Handout/
8. exp Education/
9. exp Health Education/
10. exp Psychology/
11. exp Behavior Therapy/
12. exp Cognitive Therapy/
13. exp Autogenic Training/
14. exp Suggestion/
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15. exp Hypnosis/
16. exp Counseling/
17. exp Relaxation/
18. exp Relaxation Therapy/
19. exp “Imagery (Psychotherapy)”/
20. exp Biofeedback, Psychology/
21. exp Family Therapy/
22. exp Health Promotion/
23. exp Patient Education as Topic/
24. exp Parent-Child Relations/
25. exp Skin Care/
26. exp Self-Help Groups/
27. exp Psychiatry/
28. psychodynamic therap$.ti,ab.
29. behavio$ management.ti,ab.
30. behavio$ therapy.ti,ab.
31. autogenic training.ti,ab.
32. counsel$.ti,ab.
33. psychotherapy.ti,ab.
34. suggestion.ti,ab.
35. (hypnosis or hypnotherapy).ti,ab.
36. cognitive therap$.ti,ab.
37. relaxation.ti,ab.
38. psychotherapeutic technique$.ti,ab.
39. self help.ti,ab.
40. support.ti,ab.
41. mindfulness.ti,ab.
42. imagery.ti,ab.
43. biofeedback.ti,ab.
44. family therap$.ti,ab.
45. health promotion.ti,ab.
46. health education.ti,ab.
47. patient education.ti,ab.
48. patient teaching.ti,ab.
49. patient training.ti,ab.
50. or/6-49
51. exp Eczema/px [Psychology]
52. exp Dermatitis, Atopic/px [Psychology]
53. exp Neurodermatitis/px [Psychology]
54. exp Dermatitis/px [Psychology]
55. 51 or 52 or 53 or 54
56. randomized controlled trial.pt.
57. controlled clinical trial.pt.
58. randomized.ab.
59. placebo.ab.
60. clinical trials as topic.sh.
61. randomly.ab.
62. trial.ti.
63. 56 or 57 or 58 or 59 or 60 or 61 or 62
64. (animals not (humans and animals)).sh.
65. 63 not 64
66. 5 and 50 and 65
67. 55 and 65
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68. 66 or 67
Appendix 4. Embase (OVID) search strategy
1. psychodynamic therap$.ti,ab.
2. behavio$ management.ti,ab.
3. behavio$ therapy.ti,ab.
4. autogenic training.ti,ab.
5. counsel$.ti,ab.
6. psychotherapy.ti,ab.
7. suggestion.ti,ab.
8. (hypnosis or hypnotherapy).ti,ab.
9. cognitive therap$.ti,ab.
10. relaxation.ti,ab.
11. psychotherapeutic technique$.ti,ab.
12. self help.ti,ab.
13. support.ti,ab.
14. mindfulness.ti,ab.
15. imagery.ti,ab.
16. biofeedback.ti,ab.
17. family therap$.ti,ab.
18. health promotion.ti,ab.
19. health education.ti,ab.
20. patient education.ti,ab.
21. patient teaching.ti,ab.
22. patient training.ti,ab.
23. exp psychotherapy/
24. exp education/
25. exp patient education/
26. exp health education/
27. exp psychodynamics/
28. exp behavior therapy/
29. exp autogenic training/
30. exp suggestion/
31. exp hypnosis/
32. exp cognitive therapy/
33. exp counseling/
34. exp relaxation training/
35. exp imagery/
36. exp feedback system/
37. exp family therapy/
38. exp health promotion/
39. exp child parent relation/
40. exp skin care/
41. exp psychology/
42. exp self help/
43. exp psychiatry/
44. or/1-43
45. eczema.mp. or exp ECZEMA/
46. exp DERMATITIS/ or dermatitis.mp.
47. exp atopic dermatitis/
48. neurodermatitis.mp. or exp NEURODERMATITIS/
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49. or/45-48
50. random$.mp.
51. factorial$.mp.
52. (crossover$ or cross-over$).mp.
53. placebo$.mp. or PLACEBO/
54. (doubl$ adj blind$).mp. [mp=title, abstract, original title, name of substance word, subject heading word, protocol supplementary
concept, rare disease supplementary concept, unique identifier]
55. (singl$ adj blind$).mp. [mp=title, abstract, original title, name of substance word, subject heading word, protocol supplementary
concept, rare disease supplementary concept, unique identifier]
56. (assign$ or allocat$).mp.
57. volunteer$.mp. or VOLUNTEER/
58. Crossover Procedure/
59. Double Blind Procedure/
60. Randomized Controlled Trial/
61. Single Blind Procedure/
62. 50 or 51 or 52 or 53 or 54 or 55 or 56 or 57 or 58 or 59 or 60 or 61
63. 44 and 49 and 62
Appendix 5. PsycINFO (OVID) search strategy
1. eczema.ti,ab. or exp Eczema/
2. dermatitis.ti,ab. or exp Dermatitis/
3. neurodermatitis.ti,ab. or exp Neurodermatitis/
4. 1 or 2 or 3
5. double-blind.tw.
6. random$ assigned.tw.
7. control.tw.
8. 5 or 6 or 7
9. 4 and 8
Appendix 6. CINAHL (OVID) search strategy
S1. (MH “Eczema”)
S2. eczema
S3. (MH “Dermatitis, Atopic”)
S4. neurodermatitis
S5. (MH “Dermatitis+”)
S6. dermatitis
S7. S1 or S2 or S3 or S4 or S5 or S6
S8. (MH “Psychotherapy+”)
S9. (MH “Patient Education+”)
S10. (MH “Education+”)
S11. (MH “Health Education+”)
S12. (MH “Psychology+”)
S13. (MH “Behavior Therapy+”)
S14. (MH “Cognitive Therapy”)
S15. (MH “Autogenic Training (Iowa NIC)”)
S16. (MH “Hypnosis”)
S17. (MH “Counseling+”)
S18. (MH “Relaxation”)
S19. (MH “Biofeedback”)
S20. (MH “Family Therapy”)
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S21. (MH “Health Promotion+”)
S22. (MH “Parent-Child Relations+”)
S23. (MH “Skin Care+”)
S24. (MH “Support Groups+”)
S25. (MH “Psychiatry+”)
S25. TI psychodynamic therap* OR AB psychodynamic therap*
S27. TI behavio* management OR AB behavio* management
S28. TI behavio* therapy OR AB behavio* therapy
S29. TI autogenic training OR AB autogenic training
S30. TI counsel* OR AB counsel*
S31. TI psychotherapy OR AB psychotherapy
S32. TI suggestion OR AB suggestion
S33. TI ( hypnosis or hypnotherapy ) OR AB ( hypnosis or hypnotherapy )
S34. TI cognitive therap* OR AB cognitive therap*
S35. TI relaxation OR AB relaxation
S36. TI psychotherapeutic technique* OR AB psychotherapeutic technique*
S37. TI ( “self-help” or “self help” ) OR AB ( “self-help” or “self help” )
S38. TI support OR AB support
S39. TI mindfulness OR AB mindfulness
S40. TI imagery OR AB imagery
S41. TI biofeedback OR AB biofeedback
S42. TI family therap* OR AB family therap*
S43. TI health promotion OR AB health promotion
S44. TI health education OR AB health education
S45. TI patient education OR AB patient education
S46. TI patient teaching OR AB patient teaching
S47. TI patient training OR AB patient training
S48. S8 or S9 or S10 or S11 or S12 or S13 or S14 or S15 or S16 or S17 or S18 or S19 or S20 or
S21 or S22 or S23 or S24 or S25 or S26 or S27 or S28 or S29 or S30 or S31 or S32 or S33
or S34 or S35 or S36 or S37 or S38 or S39 or S40 or S41 or S42 or S43 or S44 or S45 or
S46 or S47
S49. (MH “Clinical Trials+”)
S50. PT clinical trial
S51. TX clinic* n1 trial*
S52. (MH “Random Assignment”)
S53. TX random* alloc*
S54. TX placebo*
S55. (MH “Placebos”)
S56. (MH “Quantitative Studies”)
S57. TX allocat* random*
S58. “randomi#ed control* trial*”
S59. TX singl* n1 blind* OR TX singl* n1 mask* OR TX doubl* n1 blind* OR TX doubl* n1 mask* OR
TX tripl* n1 blind OR TX tripl* n1 mask* OR TX trebl* n1 blind* OR TX trebl* n1 mask*
S60. S49 or S50 or S51 or S52 or S53 or S54 or S55 or S56 or S57 or S58 or S59
S61. S7 and S48 and S60
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WH A T ’ S N E W
Last assessed as up-to-date: 17 January 2013.
Date Event Description
20 December 2013 New citation required but conclusions have not
changed
There has been no significant alteration to the conclu-
sions of the original review
20 December 2013 New search has been performed Five new trials have been added, making a total of 10
randomised controlled trials (RCTs)
H I S T O R Y
Protocol first published: Issue 1, 2003
Review first published: Issue 3, 2007
Date Event Description
2 October 2008 Amended Converted to new review format.
23 May 2007 New citation required and conclusions have changed Substantive amendment
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The views and opinions expressed therein are those of the authors and do not necessarily reflect those of the NIHR, NHS or the
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D I F F E R E N C E S B E TW E E N P R O T O C O L A N D R E V I E W
There were no differences between the protocol and review completed in 2007.
Differences between the 2007 review and this update are as follows.
• The objective has, for clarity, been changed from ’To assess the effectiveness of psychological and educational interventions in
changing outcomes for children with atopic eczema’ to ’To assess the effect of psychological and educational interventions for atopic
eczema in children’.
• Secondary outcomes now include adverse effects in terms of cost and inconvenience.
• Types of intervention: The description and organisation of psychological and educational interventions has been amended.
• Analysis plan: In this update, it was planned, if feasible, to assess the impact of missing data with a sensitivity analysis, to use the
I² statistic to assess heterogeneity, and to use funnel plots to assess reporting bias.
• Search methods. Not all sources searched for the 2007 review have been searched for this update. We have incorporated some
additional resources.
57Psychological and educational interventions for atopic eczema in children (Review)
Copyright © 2014 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
I N D E X T E R M S
Medical Subject Headings (MeSH)
Biofeedback, Psychology; Caregivers [education]; Dermatitis, Atopic [psychology; ∗therapy]; Family Health; Hypnosis; Nurse’s Practice
Patterns; Outcome Assessment (Health Care); Parents [∗education]; Patient Education as Topic [∗methods]; Psychotherapy; Quality
of Life; Randomized Controlled Trials as Topic; Steroids [administration & dosage]
MeSH check words
Adolescent; Child; Humans; Infant
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